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Abstract  
Background. Delayed-onset muscle soreness (DOMS) is the pain felt in skeletal 
muscle in the days following a bout of exercise.  Associated with eccentrically biased 
resistance exercise, DOMS pain can restrict activities of daily living, is a barrier to 
engagement in further exercise and can hinder sports performance.     From a public 
health point of view exercise is an important mediator of disease.  To effectively 
facilitate exercise engagement, it is important to understand the mechanisms that 
underpin DOMS and identify interventions that alleviate the symptoms.  Current 
theories of DOMS are based around the inflammatory response caused by exercise 
induced muscle damage (EIMD) leading to the sensitisation of pain receptors.  It has 
been shown that DOMS and other indices of EIMD can be blunted by ingestion of 
polyphenol compounds.  Aronia Melanocarpa is an antioxidant rich berry, the 
concentrated dried powder of this berry has been shown to have powerful antioxidant 
properties.  Establishing an evidence based exercise protocol that consistently 
elevates biomarkers is required for DOMS intervention testing, this research was 
created to establish such a protocol.  Ingesting polyphenols may attenuate indices of 
exercise-induced muscle damage.  Thus, this research investigated whether 
consuming a single dose of polyphenol rich Aronia Melanocarpa would attenuate 
biomarkers of DOMS.  The endocannabinoid Anandamide (AEA) has been shown to 
have pain modulating capability and is of interest in this research.   
 
Purpose. The purpose of this study was to design a protocol to determine the 
optimum level of exercise to induce measurable changes in the biomarkers associated 
with DOMS.  Once the protocol was established, it was then used to investigate the 
effect of a single dose of polyphenols rich Aronia melanocarpa on those biomarkers.   
 
Design.  Phase one utilised a randomised independent group design.  Twenty-five 
healthy men (31.6 ± 13.2 years; 83.2 ± 13.0 kg; 179.0 ±6.9 cm) were randomly 
assigned to perform either 48, 60 or 72 repetitions of maximal eccentric elbow flexion 
exercises.   Phase two was conducted using a randomised, single blind, placebo 
controlled independent group design.  Seventeen healthy male participants (27.1 ± 
10.2 years; 77.8 ±10.3 kg; 177.7 ± 7.0 cm) were randomly assigned to ingest either 
a placebo drink or polyphenol rich Aronia melanocarpa drink after a bout of elbow 
flexion exercises.  In both phase one and phase two, levels of the following 
biomarkers were assessed before, immediately after and 48 hours after exercise; 
DOMS, CK, IL-6, AUC, ROM and Anandamide (AEA). 
 
Results.  Phase one:  After 48 hours, the highest mean DOMS scores (VAS) were 
recorded in the 60 repetition group; 5.1cm (± 2.2) compared to 48 repetitions 4.3cm 
(± 2.1) and 72 repetitions 4.6cm (± 2.6).  However, the group differences did not 
reach statistical significance (p=0.766).  The UAC was significantly increased over 
the 48-hour period for 48 and 60 repetitions only (p=0.005 and p=0.008 
respectively).  A significant 48-hour time effect on the ROM was apparent in the 60 
repetition group (p=0.013) and 72 repetition group (p=0.018), but not 48 repetition 
group (p=0.262).  There was no statistical difference between AEA concentrations at 
any time-point.  Phase two: After 48 hours, participants in the Aronia melanocarpa 
group reported 14% less pain than in the control group with mean pain scores of 
4.4cm (±2.2) and 5.1cm (±2.2) respectively.  However, the difference in pain scores 
did not reach statistical significance (p=0.556).  After 48 hours, plasma CK had 
significantly increased by 462% (p=0.036) in the placebo group.  There was no 
significant increase in CK activity in the Aronia melanocarpa group (p=0.173).  
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Despite this, no significant difference between the two groups was found (p=0.248). 
There was a significant reduction in the ROM of the elbow joint over 48 hours of 16.5° 
(p=0.012) in the control group, but no change in ROM in the Aronia melanocarpa 
group over the same time period (p= 0.122).  Despite this, no significant group x 
time interaction (p=0.111) was found for ROM. 
 
Conclusions.  The developed exercise protocol consistently elevated biomarkers of 
DOMS and was therefore used to test the polyphenol intervention.  The findings 
indicate that a single dose of polyphenol rich Aronia melancarpa does not attenuate 
exercise-induced DOMS in healthy men.  However, Aronia melanocarpa may confer 
a small blunting effect on other indices of EIMD, specifically ROM and CK.  
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Thesis Introduction 
Evidence that exercise modulates disease states is well established and still 
accumulating (Cordero, Masiá, & Galve, 2014; Floegel & Perez, 2016; Pesta, 
Goncalves, Madiraju, Strasser, & Sparks, 2017; Swift, Johannsen, Lavie, Earnest, & 
Church, 2014), despite this only 26% of adults in the UK meet the Department of 
Health exercise guidelines (NHS, 2017).  The negative physiological effects of 
exercise can be demotivating and there is a clear need to evaluate strategies that 
moderate those effects, one such negative effect being exercise-induced pain.  
Unaccustomed, strenuous exercise often results in the sensation of pain that 
appears within a couple of days (Hough, 1900).  Given that the pain is delayed, this 
phenomenon has been termed ‘delayed-onset muscle soreness’ or DOMS.  This pain 
causes mild discomfort to debilitation depending on the intensity of the exercise 
bout, and can lessen a person’s motivation to perform further exercise (Grant, 
Zondi, Janse van Rensburg, & Jansen van Rensburg, 2015).   The underlying 
biochemical mechanisms underpinning the pain of DOMS have yet to be fully 
elucidated (Grant et al., 2015).  Despite uncertainty of the underlying cause of 
DOMS, it is clear that the research community have invested considerable time 
investigating a whole variety of interventions to alleviate the symptoms.   There is 
a suggestion that exercise-induced increases in reactive oxygen species (ROS) 
sensitise pain receptors.  ROS are a natural by-product of energy metabolism and 
are important in cell signalling.  However, ROS are chemically reactive, and become 
detrimental as high levels cause cell damage.  As ROS may sensitise pain receptors, 
is follows that nutritional interventions targeting ROS have been investigated as an 
alleviator of DOMS, antioxidant vitamins and polyphenols in particular have become 
a focus.   Evidence suggests there is some merit in the efficacy of polyphenol 
interventions in the reduction of DOMS pain, however the evidence is equivocal (J. 
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Kim & Lee, 2014).  This may in some measure be because each polyphenol 
intervention has a unique profile of polyphenolic compounds and therefore confer 
differing magnitudes of physiological effects.   To the authors knowledge the effect 
of polyphenol rich Aronia melanocarpa on the biomarkers associated with DOMS 
has yet to be examined.  From an experimental standpoint however, it is difficult to 
compare DOMS intervention studies because of the variety of methods employed 
within the research community, in particular, disparity in the number of exercise 
repetitions.  A standardised exercise protocol with a set number of repetitions that 
can be used to test several different interventions would make comparison of 
intervention studies possible.    The present study sets out to examine the 
physiological effects of three levels of exercise (48, 60 and 72 repetitions of elbow 
flexion), in order to set a level of exercise to test a polyphenol intervention on 
biomarkers associated with DOMS.     
Main Aims and objectives 
The overall aim of this thesis is to investigate biomarkers associated with exercise-
induced DOMS in humans.  The research intends to address the inconsistencies in 
DOMS inducing experimental protocols.  And further, investigate the effects of a 
single antioxidant dose on the biomarkers associated with DOMS.  These aims will 
be achieved by the following objectives: 
1. To design an evidence based DOMS induction exercise protocol. 
2. To investigate biomarkers of DOMS following three levels of exercise. 
3. To investigate the effects of a dietary polyphenol antioxidant intervention on 
biomarkers associated with DOMS. 
 
This thesis first addresses in chapter two the relevant background literature on the 
aetiology of DOMS and modalities to alleviate it.  A two phase experimental 
17 
  
 
approach is used to look at the effects of the three levels of exercise and then the 
effects of a polyphenol intervention.  Chapter three outlines phase one where 
biomarkers were measured to assess three levels of exercise.  Chapter four then 
outlines the second phase, which assesses the effects of a polyphenol intervention.  
Lastly, a short conclusion is outlined in chapter five.   
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Chapter 1  Background 
The phenomenon of delayed onset muscle soreness (DOMS), first described by 
Hough (1900), is characterised by pain and soreness in exercised skeletal muscle, 
and develops in the days following exercise.  Hough described muscle soreness, 
with a gradual onset, which began eight to ten hours after a bout of unaccustomed 
strenuous exercise.  After an initial delay, a gradual increase in pain occurs which 
peaks between 24 and 48 hours after cessation of an exercise bout (Plattner, 
Lambert, Tam, & Baumeister, 2014).  Though there is evidence that DOMS occurs 
with concentric and isometric contractions, the association between DOMS and 
unaccustomed strenuous exercise containing a significant number of eccentric 
contractions has been well documented (R. Armstrong, 1984).   
DOMS pain rated as 5, 6 or 7 out of 10 (a score of zero represented no pain and 
ten represented the worst pain imaginable) are commonly recorded following a 
number of eccentric contractions (Lau, Blazevich, Newton, Wu, & Nosaka, 2015a; 
Levers et al., 2016; Matsuda, Kan, Uematsu, Shibata, & Fujino, 2015; Pumpa, 
Fallon, Bensoussan, & Papalia, 2014; Ra et al., 2013).  This level of pain is 
unpleasant and results in functional limitations and restricts exercise performance 
(Grant et al., 2015).  Indeed, simply the fear of exercise-induced pain may reduce 
subsequent participation in physical activity (Wingo et al., 2011).  
 
The link between exercise-induced muscle damage (EIMD) and DOMS has for many 
years received focused attention.  It is apparent that the eccentric contractions 
associated with DOMS also cause a significantly greater amount of EIMD compared 
to isometric or concentric contractions (Fridén, Sjöström, & Ekblom, 1983; Gibala, 
MacDougall, Tarnopolsky, Stauber, & Elorriaga, 1995; Newham, McPhail, Mills, & 
Edwards, 1983).  It would seem to follow that EIMD and DOMS pain would be 
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related as they are both associated with heavily eccentric exercise.  However, direct 
association between indicators of EIMD and DOMS pain is often weak indicating that 
there may be an interplay with other biological processes, exercise-induced reactive 
oxygen species (ROS) for example.  Looking at the evidence comparing EIMD and 
DOMS suggests that an association is present but not fully understood.  Four 
decades ago, a weak correlation between exercise-induced ultrastructural injury 
and DOMS pain was demonstrated using muscle biopsies and electron microscopy 
(Nurenberg et al., 1992).  Later however, using joint angles, upper arm 
circumference and Creatine Kinase (CK) activity as indicators of EIMD, DOMS did 
not correlate well (Nosaka, Newton, & Sacco, 2002).  In contrast, more recent 
research reported a correlation between DOMS and CK, though the correlation was 
a weak one (Damas, Nosaka, Libardi, Chen, & Ugrinowitsch, 2016).  Overall, the 
evidence suggests the presence of DOMS can be considered an indicator that 
muscle damage has occurred (Schoenfeld & Contreras, 2013).  And further, that 
DOMS is likely to be a secondary consequence of EIMD following microtrauma to 
the muscle tissue (Lewis, Ruby, & Bush-Joseph, 2012).   
 
The negative consequences of DOMS include pain, reduced motivation to train and 
reduced performance (Grant et al., 2015).  It is therefore important to further 
understand the underlying biological mechanisms and discover strategies to reduce 
the soreness, particularly for athletes.  A diverse multitude of treatment modalities 
to alleviate the severity of DOMS pain have been explored (Cheung, Hume, & 
Maxwell, 2003).  However, the complexity and individual variation of the human 
body’s response to a bout of exercise makes research in this area a challenge and a 
clear DOMS attenuation strategy evasive.  Though evidence of attenuation 
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strategies have often been equivocal, they have provided insight for more focussed 
research directions into the aetiology and management of DOMS.  
 DOMS and exercise engagement 
DOMS as a negative consequence of exercise can reduce engagement in further 
exercise.  DOMS is an unfortunate consequence of unaccustomed strenuous 
exercise and has been experienced by most people at some point in their lives.  
Exercise though is an important part of a healthy lifestyle.  There is a large body of 
evidence documenting the health benefits of being physically active and the role 
exercise plays in many chronic conditions (Bouchard, Blair, & Haskell, 2007; 
Cordero et al., 2014; Floegel & Perez, 2016).  For example, the UK Department of 
Health emphasised the clear inverse relationship between exercise and 
cardiorespiratory, metabolic and musculoskeletal health (DoH, 2011).  Regular 
exercise also reduces the risk of certain cancers, osteoporosis and the symptoms of 
anxiety and depression (Bouchard et al., 2007).  Regular exercise has a positive 
effect on metabolism and modifiable cardiovascular risk factors, specifically; 
dyslipidaemia, hypertension and type 2 diabetes (Cordero et al., 2014).   Though 
the Department of Health actively encourage exercise behaviours and disseminate 
information of the positive health effects of exercise, adherence to exercise 
programmes is still lacking, particularly in low socioeconomic status groups (NHS, 
2018).  Self-motivation has been shown to be inversely associated with adherence 
to exercise programmes (Dishman, Ickes, & Morgan, 1980).  Unfortunately, some 
individuals that are motivated to adhere to the exercise programme reduce physical 
activity in other areas.  The phenomenon of increasing physical activity in one area 
whilst decreasing physical activity in another area is known as compensation.  The 
principal causes of these compensation behaviours in middle-aged adults has been 
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reported as fatigue and delayed-onset muscle soreness (DOMS) (Gray, Murphy, 
Gallagher, & Simpson, 2018).   
 DOMS and obesity 
Exercise-induced DOMS pain can be a barrier to exercise.  Overweight and obese 
individuals report an ‘exaggerated’ physiological response to exercise, including a 
reduced tolerance to exercise-induced pain, such as DOMS, compared to normal 
weight individuals (Wingo et al., 2011).  It is important therefore to further 
understand DOMS pain and research ways to alleviate the exaggerated pain in this 
group.  With pain reduction strategies, this group would be more able to manage 
weight and disease risk.  The prevalence of obesity in the UK is at a record high and 
is currently increasing, in 2016, 57% of women, 66% of men and 28% of children 
(2-15yrs) were overweight or obese (NHS, 2017).  The metabolic consequences of 
being obese increase the risk of cardiovascular disease, type 2 diabetes and some 
cancers.  Weight loss per se has been shown to reverse these cardiometabolic 
health risks (Patkar et al., 2017).  In addition, for every kilogram of weight loss 
there was found to be a 16% reduction in type 2 diabetes risk (Hamman et al., 
2006).  Even a relatively modest 5% reduction in body weight reduces co-
morbidities by 8% in the severely obese (Agborsangaya, Majumdar, Sharma, 
Gregg, & Padwal, 2015).   Weight loss protocols usually contain a caloric restriction 
element along with an exercise element.   In 2016, 47% of adults in the UK were 
trying to lose weight, of those, nearly 30% were using exercise as a weight loss aid 
(NHS, 2017).   Resistance training, during and following weight loss, mitigates the 
reduction in muscle mass occurring during the weight loss period (B. Kim, 
Tsujimoto, So, & Tanaka, 2015).   The exercise element usually includes an 
exercise protocol with eccentrically biased, and therefore associated with DOMS, 
exercises to protect muscle mass.    
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Though physical activity after weight loss is a determinant of subsequent weight 
maintenance (Beavers et al., 2014).  Following initial weight loss, a reduction in 
physical activity level is associated with weight regain, and is therefore considered 
an essential element of weight maintenance (Catenacci et al., 2014).  Exercise is an 
important element of a healthy lifestyle and in the management of disease risk, 
DOMS can be a barrier to that exercise.  For obese individuals the need for exercise 
to reduce disease risk is even more important as they are often at increased risk 
compared to normal weight individuals (Jago, Mendoza, Chen, & Baranowski, 
2013).  Given also that obese individuals experience an exaggerated pain response, 
reducing DOMS pain in this group is pertinent.  In addition, the DOMS pain 
reduction strategies should not be detrimental to health, repeated use of pain 
relieving drugs could be considered such.  Pain reduction strategies with positive 
health effects should be considered, such as nutritional interventions containing 
antioxidant substances. 
 DOMS, physical activity and resistance exercise. 
People may simply be finding exercise physically and mentally challenging and 
consequently are less motivated to engage.   Understanding the processes behind 
the degenerative/regenerative process of muscle repair after exercise has 
important implications in exercise engagement.  The 2018 physical activity 
statistics reveal a relatively positive picture for the UK with the majority of adults 
classified as active (NHS, 2017).  The Department of Health developed evidence 
based physical activity recommendations of 150 minutes aerobic exercise and two 
bouts of resistance training per week (Bull, 2010).  In 2016, 66% of men and 58% 
of women met the aerobic exercise recommendation.  Even though the importance 
of resistance training is widely known, only 26% of adults meet the Department of 
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health aerobic and resistance training recommendations combined (NHS, 2017).  
Pain is an important factor in exercise engagement, and can reduce the likelihood 
of an individual performing exercise on a regular basis (Vincent, Raiser, & Vincent, 
2012).  And further, DOMS reduces willingness to perform normal activities of daily 
living (Francis & Hoobler, 1987).  The link between DOMS and increases in the rate 
of perceived exertion may indicate part of the reason behind reduced exercise 
engagement (Marcora & Bosio, 2007).   
 DOMS, injury risk and immunosuppression 
In the days following exercise there are a number of acute negative physiological 
effects including increased injury risk and immunosuppression.  The phenomenon of 
DOMS in itself, has been known to disrupt training schedules for athletes, and 
reduce their ability to compete (Cheung et al., 2003).   Athletes are subject to 
intensive training programmes, exposure to high frequency and high intensity 
training increases the risk of injury (Stojmenovic, Malic, Vukasinovic-Vesic, 
Andjelkovic, & Dikic, 2017).  Though athletes become accustomed to their exercise, 
DOMS is still present albeit at a lower intensity (Mero et al., 2010).  Alterations in 
muscle recruitment patterns as a consequence of DOMS can cause stress to 
ligaments and tendons (Cheung et al., 2003).  This compensatory behaviour is 
likely to be the cause of the increased risk of injury associated with the DOMS 
phenomenon (Cheung et al., 2003).  Injury risk can be reduced by including 
recovery time for exercised muscles before the next bout of exercise, which also 
allows for recovery from DOMS pain.  During the recovery period important 
adaptations occur within the exercised muscles.  However, individuals react 
differently to exercise and recovery.  Some individuals require longer to recover 
and are consequently at greater risk of injury.  Understanding the underlying 
biological processes, including those of DOMS, allow for tailored exercise and 
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nutrition programmes which accelerate recovery while maximising adaptations to 
exercise.   
 
While an increase in training load leads to increases in DOMS and increased injury 
risk, longer training duration leads to increased rates of illness (Gabbett, Whyte, 
Hartwig, Wescombe, & Naughton, 2014).  Immunosuppression is not limited to long 
training schedules, depression of the immune system also occurs with acute 
increases in training load (Jones, Griffiths, & Mellalieu, 2016).   Adequate recovery 
time is required to maximise adaptations, e.g. hypertrophy, and minimise the 
negative effects of DOMS, increased injury risk and immunosuppression.  In 
addition, given that the immune system is sensitive to oxidative damage (Hughes, 
2000), for example exercise-induced oxidative stress, antioxidant interventions 
during the exercise recovery period could be seen as advantageous.  The last 
decade has seen a growing body of research into recovery modalities of training, 
especially in the athletic community.  The recent interest in recovery strategies is 
based on evidence that inadequate recovery can lead to accumulated fatigue and 
underperformance in a chosen discipline (Tavares, Smith, & Driller, 2017).    
 DOMS and the repeated bout effect 
There is a blunting of the EIMD response after the initial bout of resistance training, 
this is known as the ‘repeated bout effect’.  The initial bout of resistance training 
infers a protective effect against EIMD on subsequent exercise bouts (McHugh, 
2003).  The protective effect is not limited to EIMD, the initial bout also reduces 
symptoms of DOMS from subsequent bouts of resistance training.  Protection 
against DOMS has been shown to last a few days following two maximal 
contractions and more than a week after 30 low intensity contractions (H.-L. Chen, 
Nosaka, & Chen, 2012; T. C. Chen et al., 2013).  And further, the protection 
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against DOMS can last several months if the same muscles are regularly exercised 
(T. C. Chen, Chen, Lin, Wu, & Nosaka, 2009).  DOMS is most pronounced after 
eccentric unaccustomed maximal contractions, but is often apparent to a lesser 
extent within a demanding training schedule common among athletes (Mero et al., 
2010).  The action of lengthening while contracting in eccentric contractions causes 
significant EIMD due to physical damage to the muscle fibres (Fridén & Lieber, 
2001; Newham et al., 1983; Yu et al., 2004).  This type of contraction initiates a 
physiological response which manifest as inflammation, loss of muscle function, and 
is significantly associated with DOMS (Malm et al., 2004; Molina & Denadai, 2012). 
 The Endocannabinoid System (ECS) 
Endocannabinoids are implicated in the control of several systems including mood, 
appetite and pain (Watkins, 2018).  The pain relieving activity of endocannabinoids 
stems from work in animal models (Piomelli, Giuffrida, Calignano, & Rana, 1998).  
This pain relieving activity is present because endocannabinoids reduce nociception, 
which is the nervous system’s response to pain (Marzo, Bifulco, & Petrocellis, 
2004).   Exercise is known to create an anti-nociception (blocking the detection of 
pain) response and the underlying mechanism has been suggested to be partly due 
to endocannabinoids (Galdino et al., 2014).  Galdino et al. (2014) demonstrated in 
a rat model that anti-nociception following exercise was mediated by 
endocannabinoids.   The endocannabinoid system (ECS) in humans consists of 
cannabinoid receptors and endogenous endocannabinoids.  Of the known 
endocannabinoids, anandamide (AEA) and 2-arachidonoylglycerol (2-AG) have been 
the most extensively studied (figure 1).   At present two main receptors have been 
studied, CB1 and CB2, but there are known to be more.  These receptors are 
expressed in the human uterus (Iuvone et al., 2008), gut (Di Sabatino et al., 
2011), central nervous system (Gerard, Mollereau, Vassart, & Parmentier, 1991; 
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Liu et al., 2009), immune cells (Klein et al., 2003) and muscle (Cavuoto, McAinch, 
Hatzinikolas, Cameron-Smith, & Wittert, 2007) to name but a few.  These receptors 
are present in some cancer cells and cannabinoids have been demonstrated to 
exhibit anti-cancer activity which gives this system relevance in cancer research.  
Interestingly, CB2 receptors have been found to be upregulated in disease states 
such as inflammation and cancer (Iuvone et al., 2008; Lakiotaki et al., 2015).  
Serum endocannabinoid levels have been found to be associated with disease 
progression.  For example, AEA was found to be significantly lower in cancer 
patients compared to controls (Sailler et al., 2014).   It is therefore not surprising 
that cannabinoid receptors have become a focus for pharmacological treatment 
research for inflammatory disease states and cancers (Pacher, BÃ¡tkai, & Kunos, 
2006). 
 
 
          Anandamide                2-arachidonoylglycerol 
            (AEA)         (2-AG) 
Figure 1.  Endogenous endocannabinoids 
 
Physical activity per se has been shown to modulate the endocannabinoid system.  
More specifically, circulating levels of AEA have been shown to significantly increase 
to nearly double their baseline values in response to a bout of exercise and nearly 
triple following a bout of high intensity exercise (Raichlen, Foster, Gerdeman, 
Seillier, & Giuffrida, 2012; Sparling, Giuffrida, Piomelli, Rosskopf, & Dietrich, 2003).  
Interesting results using an in vitro animal model showed that 2-AG increased 
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excitation in the spinal cord leading to increased locomotive activity, suggesting 
that increases in 2-AG lead to increases in speed and force of contraction.  Song, 
Kyriakatos, and El Manira (2012) also demonstrated that excitation was further 
increased by the presence of the Reactive Nitrogen Species (RNS) Nitric Oxide.  
Taken together, the importance of endocannabinoids in exercise biochemistry would 
seem to be increasingly relevant. 
 The Aetiology of DOMS 
Based solely on observations following eccentric exercises of the finger without the 
use of blood or biopsy biomarkers, Hough (1900) believed the aetiology of delayed 
onset muscle soreness may be “due to lesions in the organ, either ruptures of the 
muscle fibres or of the connective tissue or of the nerves. It may even involve 
inflammation of the interstitial connective tissue.”  He based these conclusions on 
the muscles’ reduced capacity for work and inability to reach a full voluntary 
contraction and summated that this phenomenon was distinctly different from 
fatigue.  Since then the animal and human response to exercise has been 
extensively investigated and knowledge surrounding the physiological and 
biochemical aspects has expanded.  More recently, competing theories of the 
underlying cellular mechanisms of DOMS have been broadly categorised into six 
groups: lactic acid formation, muscle spasm, electrolyte/enzyme efflux, 
microtrauma, connective tissue damage and inflammation (Lewis et al., 2012).  
However, there is substantial biochemical overlap between these theories and the 
aetiology of the DOMS response to exercise is complex. 
1.7.1 Lactic Acid formation 
There is a persistent misconception that lactic acid formation causes DOMS.  First 
postulated by Asmussen (1956), the theory of muscular acidosis as the cause of 
DOMS pain has long been discounted (Hill, 1951).  Though lactate is formed as a 
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by-product of energy metabolism, the timecourse and magnitude of this response 
significantly differs from that of DOMS.  More specifically, blood lactate is cleared 
within an hour of exercise and therefore does not correlate with DOMS development 
over the next 48 hours.  The energy cost of concentric contractions is considerably 
higher than the energy cost of the eccentric contractions that are associated with 
DOMS.  Consequently, by-products of energy metabolism such as lactate are lower 
for eccentric contractions.  In the light of energy cost and lactate clearance, lactate 
is highly unlikely to be a factor in the causation of DOMS.  To fully disprove the 
hypothesis that lactic acid was implicated in the development of DOMS, Schwane, 
Watrous, Johnson, and Armstrong (1983) demonstrated that DOMS can develop 
without an increase in blood lactate.  
1.7.2 Muscle Spasm 
Decades after Hough’s observations, De Vries (1966) hypothesised that ‘The 
delayed, localised soreness which occurs following unaccustomed exercise is caused 
by tonic localised spasm of motor units, whose number varies with the severity of 
the pain’.  Described as a vicious cycle of pain caused by a tonic contraction 
brought about by continuous spasms of muscle fibres.   The rationale for this theory 
was based on the presence of exercise-induced ischemia and the knowledge that 
ischemia causes pain.  De Vries also suggested that pain in the muscle is caused by 
substances passing across cell membranes and gaining access to nerve endings.  
Interestingly, this part of his theory ties in with more recent research into DOMS 
and nociceptor sensitisation (Ota et al., 2018).  De Vries further reported that 
increased electrical activity represented increased contraction, and that periodic 
static stretching resulted in a reduction in electrical activity and a corresponding 
reduction in the symptoms of DOMS. These results led to the conclusion that spasm 
of muscle fibres had been reduced (measured as electrical activity) which led to the 
29 
  
 
alleviation of pain.  However, there are other possible reasons that stretching could 
alleviate pain, for example the dispersion of oedema (Bobbert, Hollander, & Huijing, 
1986).  De Vries suggested that the positive correlation between the level of pain 
and level of electrical activity was evidence for a low level tonic contraction.  
However, pain was rated on a three-point scale only which is unlikely to be a very 
sensitive instrument of pain severity: 1 slight soreness only on palpation, 2 
moderate soreness on movement or 3 limited the range of motion and interfered 
significantly with normal use.  A number of studies have subsequently shown no 
decrease in DOMS with stretching before (Johansson, Lindström, Sundelin, & 
Lindström, 1999), after (Wessel & Wan, 1994) or before and after exercise (Lund, 
Vestergaard-Poulsen, Kanstrup, & Sejrsen, 1998) exercise.  The theory of muscle 
spasm as a cause of DOMS and evidence that stretching eases the spasm does not 
seem to hold up to scrutiny in the light of more recent evidence. 
1.7.3 Creatine Kinase efflux and Calcium influx 
There is a large variability in the human CK response to exercise, including sex 
differences as a result of differing hormones (Oosthuyse & Bosch, 2017).  The CK 
response also differs with intensity and type of exercise (Tiidus, Tiidus, Ianuzzo, & 
Ianuzzo, 1983), therefore this enzyme is problematic as a marker for muscle 
damage and as a measure of DOMS.   The efflux of cytosolic CK as a consequence 
of increased membrane permeability is progressive and occurs in the days following 
eccentric exercise usually peaking in the blood on day four (a couple of days after 
DOMS).   This delay indicates that the efflux of CK is not a response to the 
mechanical muscle damage, but a response to a secondary process following that 
damage (Tidball, 2011).  In general though, eccentric exercise produces higher CK 
activity and more DOMS than other exercise types, which is most likely the reason 
CK has been linked with soreness intensity.  When pre-trained versus naïve 
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participants were taken through an eight-week protocol, five-fold higher levels of 
CK were seen only in the group that presented with DOMS (Flann, Lastayo, McClain, 
Hazel, & Lindstedt, 2011).  It is also worth noting that CK and DOMS respond 
similarly to repeated bouts of exercise, namely the repeated bout effect (RBE).  In 
the RBE, attenuation of increases in both CK and DOMS are seen on subsequent 
bouts of the same exercise (T. C. Chen, Lin, Chen, Yu, & Nosaka, 2017).  Though 
these two markers of EIMD share similarities in magnitude and timecourse, the 
consensus is that DOMS peaks a day or so before CK peaks are seen in the blood 
(Cleak & Eston, 1992).  And further, exercise-induced elevations in CK have been 
reported with and without DOMS pain (Hagberg et al., 1982; Maxwell & Bloor, 
1981; Shumate et al., 1979).  One proposed explanation of the expulsion of CK 
from exercised muscle is that this represents a protective mechanism which limits 
the depletion of adenosine tri-phosphate (ATP) (Baird, Graham, Baker, & 
Bickerstaff, 2012).  Behringer et al. (2014) suggest that the expulsion of CK allows 
for relaxation and regeneration within exercised muscle.  They proposed that the 
CK efflux is a survival mechanism for muscle fibres when subjected to very high 
energy demands.  And further, that this process prevents cell death during 
exhaustive exercise.  This theory therefore proposes that if CK has a relationship 
with DOMS, the relationship is an indirect one.  
 
Though CK efflux is unlikely to be directly implicated in the aetiology of DOMS 
(Schwane, Johnson, Vandenakker, & Armstrong, 1981), the underlying mechanism 
by which CK is expelled from cells is of interest.  Exercise-induced muscle damage 
(EIMD) causes disruption of muscle cell membranes thus increasing cell membrane 
permeability. This increase in permeability allows for the abnormal transit of large 
proteins and ions through the cell wall.  Enzymes, such as CK, are proteins that 
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usually have a limited capacity to cross the cell membrane.  However, as cell 
permeability increases due to EIMD, CK crosses the cell membrane in a seemingly 
unregulated efflux (Tidball, 2011).  During this period of membrane disruption, 
some ions also cross the cell wall as they follow their concentration gradient.  For 
example, as a consequence of reduced membrane integrity there is a calcium ion 
influx into muscle cells (Tidball, 2011).  Interestingly, calcium concentrations have 
been directly implicated in the expulsion of CK from exercised muscle.  Duncan and 
Jackson (1987) showed in vitro that the efflux of CK is dependent on the exercise-
induced rise in intracellular calcium.  And further, that the CK efflux was almost 
completely eliminated by the removal of extracellular calcium i.e. influx of calcium 
into the cell could no longer occur (Duncan & Jackson, 1987).  Though 
intramuscular calcium concentration are similar in response to both eccentric and 
concentric contraction, downstream calcium dependent pathway initiation differs 
between these types of contractions even when intramuscular calcium levels are 
the same (Vissing, Overgaard, Nedergaard, Fredsted, & Schjerling, 2008).  It 
therefore follows that the initiation of DOMS induced by eccentric contractions is not 
due to calcium influx per se.  This however, does not preclude the possibility that 
DOMS is initiated by a calcium induced downstream pathway. 
 
Type II muscle fibres are more susceptible to membrane damage (t-tubules) when 
subjected to eccentric contractions, which causes the subsequent effect on calcium 
homeostasis (Takekura, Fujinami, Nishizawa, Ogasawara, & Kasuga, 2001).  Vissing 
et al. (2008) showed that the hypertrophic effect of exercise-induced calcium 
homeostasis disruption on downstream proteolysis was absent in concentric 
contractions and only occurs with the eccentric contractions which produced DOMS.  
However, though muscle soreness was measured at 48 hours, calcium and 
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proteolytic calpain were not, missing an opportunity to further understand these 
relationships.  Previously though, it had been shown that simply reducing calcium 
with a calcium antagonist does not reduce muscle pain (Lane et al., 1986).   Taken 
together the evidence suggests calcium efflux is unlikely to be the cause of DOMS. 
1.7.4 Inflammatory response 
Exercise-induced muscle damage presents as microtrauma to muscle fibres, 
specifically myofibrils show z-band streaming, broadening and sometimes total 
disruption (Fridén et al., 1983).   The damage is followed by the inflammatory 
response and a subsequent shift in fluids and electrolytes.   The extra fluid volume 
manifests as oedema and the exercised limb becomes swollen (Felipe Damas et al., 
2016).   Earlier research showed that DOMS and swelling shared the same 
timecourse but no causal link was found(Howell, Chleboun, & Conatser, 1993).  The 
conclusion was that other chemical mediators were present following exercise which 
altered the threshold for pain, together with the additional pressure was then 
interpreted as pain.  
 
To investigate increased intramuscular fluid pressure and pain perception, Wolff, 
Potter, Vermeer, and McEwen (1961) injected saline into the human gastrocnemius.  
Injecting at higher volumes and at faster speeds caused the most pain leading to 
the conclusion that volume and pressure were both important in the perception of 
pain.  They further concluded that fluid pressure altered the pain threshold and that 
the pain threshold differed by age and gender (Wolff & Jarvik, 1965).  Given the 
link between increased fluid pressure and increased pain sensitivity it seemed 
plausible that inflammatory pressure and DOMS were related.  However, DOMS 
pain is persistent and in the above gastrocnemius injections, the pain was 
transient, i.e. the pain occurring from the saline injections was relieved after a few 
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minutes as the fluid dispersed.  It seems possible though, that in the case of 
exercise-induced oedema, the fluid is kept in place by concentration gradients and 
therefore does not disperse in the same way.  And further, that the reduction in 
DOMS pain on exercising (R. Armstrong, 1984) or stretching (De Vries, 1966) the 
affected muscle is a temporary dispersal of fluids as they are forced out of the 
muscle.  More recent investigations into fluid pressure and DOMS injected saline 
directly into DOMS affected muscles (Gibson, Arendt-Nielsen, Taguchi, Mizumura, & 
Graven-Nielsen, 2009).  Pain increased only when saline was injected just inside 
the muscle fascia versus deep intramuscular injection.  This may indicate that 
pressure increases just beneath the fascia of the muscle is implicated in the 
aetiology of DOMS, not simply intramuscular pressure (Gibson et al., 2009).  
 
Intramuscular pressure (IMP) during exercise has been shown to be significantly 
higher for eccentric contractions as opposed to concentric contractions (Friden, 
Sfakianos, & Hargens, 1986).  Furthermore, when the resting IMP was measured 
two days after the contractions that was still the case.  As DOMS was only 
experienced in the eccentrically exercised limb, it was concluded that IMP was a 
factor in the aetiology of DOMS (Friden et al., 1986).  In contrast to Friden’s 
findings, more recent research has shown that intramuscular pressure (IMP) is not 
an indicator of DOMS (Crenshaw et al., 1995).  Crenshaw et al demonstrated the 
same peak IMP for concentric and eccentric leg exercises while DOMS was only 
reported for the eccentric group.  This led to the assumption that IMP was not an 
indicator of DOMS.  However, IMP was only measured during the exercise protocol 
and not while the participants were experiencing DOMS two days later, which 
created ambiguous findings.  Friden’s findings that IMP and DOMS occurred 
together on day two only for eccentric contractions does not show a causal link.  
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However, these findings may indicate that the underlying processes associated with 
oedemic pressure are relevant in the aetiology of DOMS.  
  
Limb volume has been used as an indicator or inflammatory pressure and compared 
with the timecourse of DOMS.  Both DOMS and persistent oedema are associated 
with eccentric muscular actions.  Though limb volume increases are seen for both 
eccentric and concentric actions immediately after exercise, the volume remains 
elevated only following eccentric contractions (Talag, 1973).  This may explain 
Crenshaw’s IMP findings above.  Talag demonstrated that limb volume did not 
correlate with DOMS pain, in that DOMS pain peaked at 48 hours and limb volume 
was still increasing at 72 hours (Talag, 1973).  Later research confirmed the 
disassociation of these events (Bobbert et al., 1986).   
 
It has been proposed that this increase in limb volume is two-fold in that there is 
an increase in fluid volume followed later by an increase in structural components 
e.g. connective tissue during the regeneration process.  The initial increase in fluid 
volume not being associated with DOMS (Smith, 1991).   This seems plausible in 
the light of Talag’s findings that initial oedema present immediately after exercise is 
present in limbs that do not go on to develop DOMS.  There are inherent issues 
with limb volume as a measure of intramuscular pressure in that there is no 
differentiation between intra- and extra-cellular volumes.  In addition, extra-cellular 
volume increases may be intravascular due to increased blood flow. 
 
Increased intramuscular pressure present in oedema is a likely contributor to the 
reduced pressure pain threshold present in DOMS.  Palpation and active movement 
of muscles with DOMS is painful, this may be in part due to pressure increases 
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activating mechanoreceptor nerve endings (Lewis et al., 2012).  The aetiology of 
DOMS is complex and is not due to one single factor such as intramuscular 
pressure.  It is likely that DOMS is the result of oedemic pressure increases in 
conjunction with pain sensitisation brought on by another element of the 
inflammatory response to EIMD (Behringer et al., 2014; Smith, 1991).   
1.7.5 Microtrauma and Muscle Regeneration 
The link between muscle damage and the pain associated with DOMS is complex.  
Extensive intramuscular microtrauma caused by eccentric exercise was 
demonstrated in humans by Fridén et al. (1983).  The height of damage to 
myofibrils on day three corresponded with the development of DOMS. Though the 
underlying biological mechanism was not yet apparent, their work gave credence to 
the theory that intramuscular microtrauma is important in the aetiology of DOMS.  
Since then, individual aspects of this relationship have been investigated using 
blood biomarkers and muscle biopsy results in both human and animal models.  In 
an animal model Takekura et al. (2001) demonstrated microtrauma to type two 
fibre membranes caused by eccentric exercise, more specifically, the physical and 
chemical disruption of membrane systems.  In humans, muscle damage following a 
bout of eccentric exercise caused increases in satellite cell (SC) proliferation as part 
of the regeneration of myofibres (Chargé & Rudnicki, 2004).   Interestingly, whey 
protein supplementation resulted in significant increases in SC proliferation in 
exercised muscles and also resulted in significantly higher DOMS scores compared 
to placebo.  These results may indicate that SC proliferation in the muscle 
regeneration process is involved in the pain associated with DOMS.  The 
aforementioned SC proliferation increases were recorded in Type II muscle fibres, 
where the number of SC’s doubled.   SC proliferation peaked at 48 hours post 
exercise which has been shown to follow the same timecourse as DOMS pain (Farup 
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et al., 2014).  It was later shown that part of the regeneration process, namely, 
increases in ‘glial cell line derived neurotrophic factor’ and ‘nerve growth factor’ 
produced by muscle fibres/SC’s were crucial in the development of DOMS 
(Mizumura & Taguchi, 2016).   
1.7.6 The Immune Response and Pain Sensitisation  
The inflammatory response to exercise begins in earnest within minutes of 
exercise-induced muscle damage with a cascade of molecules released in the acute 
phase response.  Elements of this response last for several days while the repair 
and regeneration process of the exercised muscles is underway.  It is known that 
the immune response to exercise results in significant increases in circulating 
leukocytes, lymphocytes and monocytes in the blood (Malm et al., 2000).   The 
release of pro-inflammatory agents by immune cells has been linked to increased 
pain sensitivity (Fatouros & Jamurtas, 2016).  Attempts to elucidate the immune 
response within the exercised muscle has become a focus in recent years.  
Although individual immune system biomarkers following a bout of exercise have 
been extensively investigated, several aspects of this response and the relationship 
to DOMS remain unclear.   
 
DOMS pain involves activation of pain afferents within skeletal muscle, that is 
sensations of pain sent via nociceptor sensory neurons.  The pain sensations are 
initiated when potentially harmful stimuli, either mechanical, thermal or chemical 
act on nociceptors sending pain signals to the brain. There is evidence that 
elements of the immune response are responsible for a change in the nociception 
threshold, causing a state of hyperalgesia (Ota et al., 2018).  It follows therefore 
that elements of the immune response are implicated in the aetiology of DOMS.  A 
prevailing theory of DOMS is that damage to sarcomeres leads to cell death and 
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elements of the subsequent immune response increase nociceptor pain sensitivity 
due to the presence of chemical mediators (Clarkson & Hubal, 2002; Hyldahl & 
Hubal, 2014).  Specific noxious substances have been implicated, for example, E 
series prostaglandins and Nerve Growth Factor (NGF) (Murase et al., 2010; Ota et 
al., 2018).   
 
NGF is upregulated in the muscle following eccentric contractions and has a 
comparable time course to DOMS, this indicates a possible involvement in DOMS 
aetiology (Hyldahl & Hubal, 2014).  In an animal model upregulation of NGF was 
completely suppressed by blocking the receptor before exercise.  An intramuscular 
injection of B2 Bradykinin receptor antagonist led to the absence of NGF from this 
pathway which in turn resulted in the absence of DOMS following eccentric 
contractions.  And further, antibodies to NGF injected intramuscularly two days 
after the exercise at the height of DOMS pain, completely attenuated DOMS. These 
results suggest that NGF upregulation through the B2 Bradykinin pathway is 
essential in the aetiology of DOMS.  Interestingly, intramuscular injections of 
bradykinin alone, i.e. without eccentric contractions, did not produce DOMS, 
indicating that this biochemical pathway does not work alone to induce pain 
(Murase et al., 2010).  A recent review of neuropathic factors in the aetiology of 
DOMS concluded that NGF plays a crucial role in DOMS pain (Mizumura & Taguchi, 
2016). 
 
Another suggestion is the increases in macrophage activity is related to DOMS as it 
shares the same 24/48 hour timecourse.  Given that macrophages produce 
prostaglandins, which are implicated in nociceptor sensitisation, there may be 
credence in this theory (Smith, 1991).  A significant correlation has been shown 
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between prostaglandin E2 and DOMS pain, adding further weight to the theory that 
the immune response and DOMS are tightly linked (Uchida et al., 2009).   
 
An investigation into leukocyte infiltration into exercised muscle and the symptoms 
of DOMS showed no significant relationship (Malm et al., 2000).  However, Malm et 
al. (2004) in later research concluded that there was a significant difference in the 
immune response of participants that had a DOMS score above 3 versus those 
categorised without DOMS (scores below 3).   His later results indicated that one 
element of the immune response was an essential factor in DOMS pain following a 
bout of exercise.  Specifically, a significant correlation between granulocytes in the 
epimysium and DOMS pain.  However, this was the only immune measure that 
correlated with DOMS leading to the final conclusion that there was no difference in 
the immune response between uphill (not eccentric) and downhill (eccentric) 
exercise, despite only the downhill group experienced DOMS.  This may indicate 
that DOMS is related to the immune response of the individual person and not the 
type of exercise performed or resultant EIMD.  It also has to be said that the 
inflammatory response to exercise is not the same across the board.  In some 
individuals this response occurs with concentric exercise and does not always occur 
in response to eccentric exercise. 
 
Much evidence exists both for and against the involvement of the inflammatory 
response in the aetiology of DOMS.  One possible reason for lack of evidence in the 
causation of DOMS is the difficulty in evaluating the inflammatory response in live 
human muscle tissue.  There are inherent issues in identifying immune cells from a 
small muscle biopsy sample.  Armstrong suggests that inflammation may be 
localised in muscle tissue and ‘missed’ when muscle biopsies are taken for analysis 
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(R. B. Armstrong, 1986).  On this point, participants report DOMS pain being more 
pronounced in different areas of the muscle, distally, proximally or in the middle, 
and that this changes over time (Bobbert et al., 1986). 
 
In conclusion, DOMS is likely the result of the immune response causing 
intracellular and extracellular matrix disruptions, however, the exact mechanisms of 
this reaction remains unclear (Stauber, Clarkson, Fritz, & Evans, 1990).  
1.7.7 Reactive Oxygen & Nitrogen Species  
Reactive Oxygen Species (ROS) and Reactive Nitrogen Species (RNS) are naturally 
produced in muscle and increases on exercise (figure 2).  Collectively known as 
Reactive Oxygen & Nitrogen Species (RONS), these free radicals are known to be 
both metabolically essential and physically damaging molecules.  Increased oxygen 
metabolism as a result of exercise increases free radicals and associated damage 
(Davies, Quintanilha, Brooks, & Packer, 1982).  For example, during exercise, 
leukocyte production increases to release proteolytic enzymes and synthesising 
cytokines such as interleukin-6 (IL-6).  During this process, reactive oxygen species 
are created (Fatouros & Jamurtas, 2016).  ROS reducing enzymes may be unable to 
keep pace with free radical formation as oxygen usage increases, this leaves the 
cells vulnerable to oxidative damage (Higuchi, Cartier, Chen, & Holloszy, 1985).  
Antioxidant nutrient deficiency exacerbates exercise-induced muscle damage 
because of the body’s inability to effectively scavenge the increased ROS (Ji, 1995).  
Interestingly, this ‘under capacity’ to scavenge ROS and avoid ROS induced damage 
may be a contributory factor in individual variation in muscle damage biomarkers.   
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Figure 2. Overview of the regeneration and repair process in exercised muscles 
(Kendall & Eston, 2002) 
 
While low levels of ROS are essential for normal cell signalling, high levels of ROS 
promote contractile dysfunction, more specifically, fatigue and force loss (Powers & 
Jackson, 2008).  Increased ROS can also lead to pain, e.g. in an animal model, 
intramuscular injection of the reactive oxygen species (H2O2) increased nociceptor 
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activity (p=0.0004) and consequently pain behaviours in rats (Sugiyama, Kang, & 
Brennan, 2017).  The RNS nitric oxide is a signalling molecule that increases in the 
muscle during exercise.  In a review of human studies, it has been proposed that 
nitric oxide plays a role in the pain associated with DOMS (Radak, Naito, Taylor, & 
Goto, 2012).  Eccentric exercise that produces soreness ratings of 7 out of 10 is 
accompanied by a threefold increase in Nitric Oxide and a significant increase in 
DNA oxidation in skeletal muscle (Radák, Pucsok, Mecseki, Csont, & Ferdinandy, 
1999).  
 
Downhill running is an exercise that increases ROS production (G. L. Close et al., 
2005).  To evaluate the relationship between ROS and DOMS, the response 
between downhill running versus flat running were compared, i.e. eccentrically 
biased downhill running is known to produce soreness.  As expected, significant 
increases in both ROS and DOMS occurred following the eccentric exercise protocol 
and a temporal relationship between ROS production and DOMS was demonstrated.  
However, there was a timecourse disassociation; ROS was still increasing at 72hrs 
and DOMS peaked at 48hrs.  These results lead to the conclusion that; though 
increases in soreness and ROS resulted only from eccentric exercise, there was a 
disassociation in the temporal relationship between these two responses (Close, 
Ashton, Cable, Doran, & MacLaren, 2004). Despite the dissociation, it is possible to 
reduce DOMS with substances that target ROS (Udani, Singh, Singh, & Sandoval, 
2009). 
 Attenuation of DOMS 
Proposed strategies to reduce the symptoms of DOMS have met with limited 
success.  Interventions that did not reduce the symptoms of DOMS include: cold 
water immersion (Glasgow, Ferris, & Bleakley, 2014), massage before exercise 
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(Garrido, Oliveira, Mendes, Sousa, & Sousa, 2013), topical arnica (Pumpa et al., 
2014), ginger supplementation (Matsumura, Zavorsky, & Smoliga, 2015; Tanabe et 
al., 2015), curcumin supplementation (Tanabe et al., 2015), and Omega 3 
supplementation (Jakeman, Lambrick, Wooley, Babraj, & Faulkner, 2017).  
Interventions where reductions in pain scores reached significance include; contrast 
water therapy (Bieuzen, Bleakley, & Costello, 2013), neuromuscular electrical 
stimulation (Taylor et al., 2015), exercised limb occlusion (Page, Swan, & 
Patterson, 2016), NSAIDs (Morelli, Brown, & Warren, 2018) and Montmorency 
cherry supplementation (Bell, Stevenson, Davison, & Howatson, 2016; Connolly, 
McHugh, & Padilla-Zakour, 2006).   Post-exercise massage reduces the symptoms 
of DOMS but the effect is minimal, and further, under which conditions the massage 
is effective is still unclear (Poppendieck et al., 2016).   
1.8.1 Supplementation strategies 
Interventions using fruit extracts such as Montmorency cherry supplementation 
have been showing promising results.  However, the effect of antioxidant 
interventions may be limb specific, e.g. chronic supplementation of pomegranate 
juice has been shown to significantly reduce DOMS for knee extensors but not 
elbow flexors in the same participants (Ammar et al., 2016).  Interestingly, DOMS 
scores were more than double for knee extensors compared to elbow flexors, which 
may have contributed to the non-significant result (Ammar et al., 2016).   It is 
clear that there is merit in the theory that antioxidant interventions reduce 
oxidative stress and have a reducing effect on DOMS soreness.  The exact mode of 
action, limb specificity and which particular antioxidant interventions are most likely 
to have an effect require further investigation.   
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Oxidative stress, from increased reactive oxygen species (ROS), following a bout of 
intense exercise can be moderated by dietary phytochemical supplementation 
(McLeay et al., 2012).  In addition, DOMS has been reduced by targeting ROS with 
polyphenols (Ammar et al., 2016).   The reduction of exercise-induced oxidative 
stress with polyphenols has received focussed attention in recent years.  
Polyphenols, an important group of phytochemicals, are found naturally in plants 
and known for their antioxidant capacity.  Berry fruits contain anthocyanins and 
proanthocyanidins, two important classes of polyphenols which confer their reputed 
antioxidant capacity.  Antioxidant rich food and drink may moderate the depression 
of the immune system common during a demanding training schedule without 
interfering with training adaptations (Nieman & Mitmesser, 2017).  Known for their 
antioxidant qualities, Aronia melanocarpa berries have high concentration of 
anthocyanins which reduce oxidative stress.  For example, Aronia in juice form has 
been shown to reduce oxidative stress in triathletes (García-Flores, Medina, 
Cejuela-Anta, et al., 2016; García-Flores, Medina, Oger, et al., 2016), and 
positively modulate the immune system (in vitro) (Ho et al., 2014).  And further, 
there is a synergistic effect of combining exercise with the ingestion of Aronia juice 
on the improvement of oxidative stress (Medina et al., 2012).  The anthocyanins 
reduce the exercise-induced oxidative stress while the exercise increases 
bioavailability of the anthocyanins in the Aronia juice (García-Flores, Medina, Oger, 
et al., 2016; Villaño et al., 2016).   
 
Though anthocyanins mop up RNOS per se, this has a further effect on 
inflammatory markers such as interleukin-6 (IL-6).  The immune system is complex 
and responds to a bout of exercise with an acute phase response characterised by a 
cascade of biological molecules to modulate the repair and regeneration process.  
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During the recovery period elevated levels of the inflammatory cytokine interleukin-
6 (IL-6) is apparent.  This marker usually returns to baseline within a few days 
(Van De Vyver & Myburgh, 2012).  Following a single bout of resistance training the 
IL-6 cytokine peaked between 4 and 8 hours (Louis, Raue, Yang, Jemiolo, & 
Trappe, 2007).  Dietary interventions can attenuate the IL-6 inflammatory 
response, for example, anthocyanin rich cherry juice has been shown to reduce the 
IL-6 response compared to a placebo.  Interestingly, the cherry juice intervention 
also attenuated DOMS, pain scores returned to baseline levels by 72hrs for the 
cherry juice group whilst pain scores for the placebo group did not (Bell et al., 
2016; Clifford, Bell, West, Howatson, & Stevenson, 2016).  The reduction of pain 
and attenuation of elements of the immune response are both considerations for 
exercise recovery. 
 Conclusions 
It is important to rest and recover following a bout of exercise and get to the next 
bout as quickly and optimally as possible, including recovery from the pain of 
DOMS.  The pain of DOMS interferes with activities of daily living and a person’s 
willingness to participate in exercise and rehabilitation.  It is important to discover 
approaches that alleviate the soreness and restore a person’s willingness to 
perform exercise and activities of daily living without compromising the intensity of 
these activities (Gulick & Kimura, 1996) .  However, techniques designed to speed 
up recovery time do not always produce the desired long term effects and are 
sometimes poorly understood.   Specifically, techniques that minimise recovery 
time by moderating the underlying biological processes involved in EIMD and DOMS 
may be detrimental to the positive recovery process, the hypertrophic effects of 
exercise for example may be interfered with (Schoenfeld, 2012).  It is vital to 
discover approaches that reduce DOMS without losing the beneficial adaptive 
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responses of the preceding exercise session.  An increased understanding of the 
complex relationship between the biochemical processes involved in EIMD, 
inflammation, oxidative stress and DOMS, will assist athletes and recreational gym 
users to generate positive physiological adaptations whilst alleviating the negative 
effects of exercise.  
Interventions to reduce this uncomfortable physiological response to exercise whilst 
maintaining the body’s ability to maintain/increase muscle mass are receiving much 
attention. However, underlying mechanisms and attenuation strategies for DOMS 
pain remains unclear which impacts on the efficacy of these treatment modalities.  
Understanding the degeneration/regeneration cycles are crucial to elucidate of the 
aetiology of the DOMS phenomenon (Hyldahl & Hubal, 2014).  As knowledge in this 
area develops, approaches to facilitate healthy muscle repair while alleviating the 
symptoms of DOMS will become clearer.  It will then be possible to personalise 
exercise and rehabilitation programmes to suit the individual with consideration to 
the increases in injury risk and metabolic load.  Discovering how a person will 
physiologically respond to an exercise regime can be used to tailor programmes 
that maximise recovery, maximise positive adaptations and minimise injury risk.   
 
The application of DOMS biochemistry research to the ‘real world’ is a challenge as 
the human physiological response to exercise is complex.  In addition, evaluating 
exercise biochemistry research is complicated by varying methodologies, making 
inferences and generalisations problematic. There is a wealth of research using 
these markers following muscle damaging exercise, however, differences in 
methodology make direct comparison a challenge (Kerksick, Willoughby, Kouretas, 
& Tsatsakis, 2013).   There is also a large variability of response to muscle 
damaging exercise.  On an individual level, muscle damaging exercise causes 
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varying degrees of change in each biological element, DOMS, CK and IL-6 for 
example.  Furthermore, the response varies depending on a number of factors 
including: age, sex, training status, body composition etc.  There is now a growing 
body of evidence suggesting that genetics also play a role in the human response to 
exercise (Baumert, Lake, Stewart, Drust, & Erskine, 2016).  On a cellular level, the 
biochemistry involves an interplay between several systems with a vast network of 
signalling activity.  The ‘crosstalk’ between these systems is complicated which 
makes intramuscular changes a challenge to accurately measure in vivo, 
particularly in humans.  Secondary biomarkers such as Creatine Kinase and 
Interleukin-6 have been used as proxy markers for muscle damage and the 
associated biochemistry.  
 
From a research perspective, it would be useful to establish an evidence based 
testing protocol which can be used to test new DOMS relieving approaches.   There 
have been many antioxidant interventions tested, including polyphenol 
interventions.  However, the effects of polyphenol rich Aronia melanocarpa on the 
symptoms of DOMS have yet to be examined.  
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Chapter 2  Phase one: DOMS Induction Protocol 
Development  
 Introduction 
A valid protocol to consistently induce muscle damage and initiate measurable 
changes in associated biomarkers is required to elucidate the physiological and 
biochemical aspects of delayed-onset muscle soreness (DOMS).  For example, 
changes in soreness following exercise-induced muscle damage (EIMD) can be 
compared to clarify the effects of nutritional and physical interventions.  EIMD is 
associated with changes in limb circumference, DOMS, range of motion (ROM), 
creatine kinase (CK) and interleukin-6 (IL-6) concentrations to name but a few.   
2.1.1 DOMS induction 
There is a significant time effect on EIMD biomarkers following a bout of exercise.  
In response to muscle damaging exercise, the pain associated with DOMS, CK 
concentrations and limb circumference increase as the ROM decreases.  The 
magnitude and timecourse of these changes however are not uniform and subject 
to variability in the human response and differences in experimental protocols.   
Measurable changes in these biomarkers, large enough to record significant 
differences is required to test nutritional and exercise interventions.  Isokinetic 
dynamometry is one of the safest and most effective ways to perform exercise 
testing.  Strength testing results using the Cybex Norm isokinetic dynamometer 
have been shown to be highly reliable (Impellizzeri, Bizzini, Rampinini, Cereda, & 
Maffiuletti, 2008).  Once the angles and velocity of the dynamometer are correctly 
pre-set to isolate a single muscle group, joint overload, muscle overload, and risk 
of injury are reduced.  A targeted amount of exercise-induced muscle damage 
(EIMD) can be produced by performing eccentric contractions within an isolated 
muscle group.   Maximally resisting the rotating action of the dynamometer loads 
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the isolated muscle group to maximum capacity over the full range of motion 
(Payton, Burden, British Association of, & Exercise, 2018).  The mean range of 
motion (ROM) of the elbow joint in a large sample of adult men 20-44 years was 
reported as 144.6⁰ (Soucie et al., 2011).  This ‘normative value’ provides a guide 
for dynamometry settings which are then set at a slightly reduced ROM to ensure 
safety, usually 120⁰.  For research purposes, elbow flexion exercises begin at 10⁰ 
from full extension through to 130⁰ (towards full flexion but not fully flexed). 
 
There appears to be a difference in magnitude of exercise-induced muscle damage 
(EIMD) between the upper and lower extremities.  A comparison between the 
response to eccentric exercise performed by legs versus arms shows the 
percentage reduction in strength and the CK increase was significantly greater for 
arms.  This response was most notably 72 and 96 hours post exercise.  These 
results suggest that muscle damage is greater and recovery slower in arms versus 
legs, this may in part be due to normal use of the legs in daily living (Jamurtas et 
al., 2005).  The magnitude of the increased muscle damage in the arms compared 
to the legs has been suggested to be 5-fold, based on the differences in plasma CK 
levels (Morelli et al., 2018).  
 
To evaluate differences in response to eccentric exercise by arm dominance, 
eighteen men performed 60 maximal eccentric contractions of elbow flexors four 
weeks apart using the contralateral arm.  There was found to be no significant 
differences between the dominant and non-dominant arm for CK, upper arm 
circumference and muscle soreness.  That being said, a weak correlation was 
recorded for the magnitude of these changes between collateral arms (Newton, 
Sacco, Chapman, & Nosaka, 2013).  However, even though dominant/non 
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dominant arm bout order was randomly assigned and the bouts were separated by 
four weeks, a repeated bout effect was also reported which could have confounded 
the results.  Despite the unlikeliness of a different response between the dominant 
and non-dominant arm, it seems prudent to randomise or stratify by arm 
dominance.  And further, when EIMD and DOMS is induced in only one arm the 
non-dominant arm is used as the soreness interferes less with daily tasks.  
 
Quantification of pain is difficult as pain perception is subjective and individual 
(Ohnhaus & Adler, 1975).  The pressure pain threshold or a visual analogue scale 
(VAS) are in common use for the evaluation of pain in DOMS research.  Of the two, 
the 10cm VAS is less invasive and easier to compare across studies.  There are 
however limitations of using a closed-ended VAS scale, in that a person may mark 
10 for severe pain on day one and have nowhere to mark the scale if the pain is 
worse the following day.  And further, one person may mark a 5 when their pain is 
severe and another may mark a 5 when their pain is moderate.  To alleviate that 
issue VAS pain scales have descriptive terms for pain alongside the numbered 
scale; 0 - no pain, 6 – severe pain and 10 – worst pain imaginable.  
Notwithstanding some limitations, the 10cm VAS has been successfully and 
consistently used to quantify pain in DOMS research (Ammar et al., 2016; Matsuda 
et al., 2015; Pumpa et al., 2014). 
2.1.1.1 Eccentric contractions 
Since Hough (1900) identified the distinct phenomenon of DOMS which occurs 
following voluntary eccentric contractions of untrained muscles, DOMS association 
with exercise bouts containing a high element of eccentric contractions has been 
well documented (Asmussen, 1956; Molina & Denadai, 2012).  The use of 
dynamometry in exercise research ensures that when investigating DOMS, 
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contractions are eccentric in nature and the concentric action is eliminated with a 
passive reset of the dynamometer arm.  Combined with instructions to maximally 
resist the dynamometer arm during eccentric action, muscle damage is initiated.  
Contractions that are maximal in nature produce the most marked physiological 
and biochemical response, i.e. the process of eccentrically lengthening while 
maximally contracting, and the high tensile forces produced, result in a greater 
level of damage to the muscle fibres on a microscopic level (Yu et al., 2004).  The 
ensuing exercise-induced muscle damage (EIMD) is responsible for a cascade of 
biochemical responses resulting in measurable increases in DOMS, enzyme activity 
and inflammation markers, for example, increased concentrations of CK (Tiidus et 
al., 1983) and IL-6 (Arakawa et al., 2016).   The most pronounced pain from 
eccentric contractions is when those contractions are performed after an ‘exercise 
free’ period and are not influenced by the repeated bout effect.  In the RBE, 
exercise-induced changes in biomarkers, such as CK and IL-6, are less pronounced.  
Therefore, it is normal procedure in exercise research to restrict exercise for a few 
days before testing takes place in an attempt to partially eliminate the RBE.   
2.1.1.2 Speed, set, repetition and rest configuration.  
Exercise to induce the greatest changes in biomarkers usually includes a number of 
maximal eccentric contraction for the reasons outlined above.  It is also the case 
that short inter-set rest intervals of 60s or less may be useful to increase 
measureable metabolic stress (Grgic, Lazinica, Mikulic, Krieger, & Schoenfeld, 
2017).  Probably the most important consideration after the type of contraction, is 
the number of contractions, as the number of contractions heavily influences the 
physiological and biochemical response.  On this point, Nosaka et al. (2002) 
recorded peak pain scores 48 hours after exercise, and found a significantly less 
pain after 12 repetitions (2.5cm) compared to 60 (3.7cm) repetitions of elbow 
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flexion.  In DOMS research, several sets of maximal eccentric elbow flexion 
exercises produce a variety of pain scores, usually ranging between 3cm and 6cm 
on a 10cm VAS.  These scores are likely to be more influenced by the number of 
repetitions and less influenced by the set, repetition configuration.  For example, 
muscle soreness following 30 repetitions of maximal eccentric elbow flexion 
exercises did not differ whether the configuration was 10 x 3 repetitions or 3 x 10 
repetitions.  There were no significant differences in strength, cross sectional area 
(biceps brachii) or DOMS (Chan, Newton, & Nosaka, 2012).  On performing 60 
maximal eccentric contractions of the elbow flexors significant changes in 
biomarkers have been recorded as follows; reduced muscle strength (Panza et al., 
2016); and; reduced ROM and increased DOMS UAC and CK (Newton et al., 2013; 
Nosaka et al., 2002). 
 
In exercise research, the exercise protocol is complex and dependent on factors 
that may not be the same from one research setting to another.  For example, how 
well the researcher motivates the participant to maximally resist the dynamometer 
arm and the length of time the contraction is held, both of which are determinants 
of the level of muscle damage produced.  The increase in delayed soreness 
associated with slower, longer held contractions was first noted by Hough (1900).  
With the use of modern technology in the form of isometric dynamometry the 
speed and length of contractions can be quantified and biochemical responses 
compared.  When 36 eccentric contractions were performed at an angular velocity 
of either 30 degrees/second or 180 degrees per second the physiological response 
was greater at the slower speed(Paddon-Jones, Keech, Lonergan, & Abernethy, 
2005). The inflammatory response (measured as upper arm circumference) for 
example, was significantly greater at 24 hours in the slower 30 degrees/second 
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group.  And further, measurements of muscle soreness peaked faster (24hrs) and 
returned to baseline quicker with slow contractions at 30 degrees/second (Paddon-
Jones et al., 2005).  More recent research reported that dynamometer speeds of 
180 degrees/second induces less electrical activity in the muscle compared to 60 
degrees/second (Greig & Marchant, 2014).  The lower electrical activity was evident 
in the resulting peak torque measurements which was significantly higher for 60 
degrees/second compared to 180 degrees per second (Greig & Marchant, 2014).  
Greater torque may begin to explain the more marked increases in biomarkers at 
slower speeds.  Maximal eccentric elbow flexion exercises at an angular velocity of 
60°/sec provides a slow and more damaging contraction of the biceps brachii (Greig 
& Marchant, 2014; Hody, Rogister, Leprince, Wang, & Croisier, 2013). 
2.1.2 Indirect muscle damage markers  
Following a bout of exercise two types of pain may develop, pain immediately after 
the exercise and the delayed pain of DOMS.  The delayed pain of DOMS is generally 
only present in resting muscles as a dull ache but is intensified by stretching or 
palpating the muscle.  A common method to assess the level of pain is pain on 
movement of the exercised muscles recorded on a visual analogue scale (VAS), a 
10cm (100mm) scale from ‘no pain’ at one end to ‘worst possible pain’ at the 
opposing end.  Although pain is subjective, asking participants to indicate their level 
of pain by marking on a 10cm line in this way has been shown to be a reliable 
measure (Bahreini, Jalili, & Moradi-Lakeh, 2015; Mattacola, Perrin, Gansneder, 
Allen, & Mickey, 1997).  In DOMS research, VAS scores are used to compare pain 
between experimental groups to assess the response to an intervention (Glasgow et 
al., 2014; Matsumura et al., 2015; Romain et al., 2017).  Using the VAS method of 
assessing pain in the biceps brachii, Tanabe et al. (2015) recorded a peak in DOMS 
pain at 48 hours post exercise.  Jubeau, Muthalib, Millet, Maffiuletti, and Nosaka 
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(2012) and Matsuda et al. (2015) concur, recording pain scores that peaked 48 
hours after the exercise protocol. 
2.1.2.1 Creatine Kinase  
Following a bout of strenuous prolonged exercise, the rise in CK is likely the result 
of muscle damage causing a loss of membrane integrity in the exercised muscles.  
However, there is controversy concerning how accurately the rise in CK reflects the 
type and intensity of the exercise performed.  It has also been suggested that the 
release of CK into the blood is an indication of disturbances in energy production 
processes rather than muscle damage per se (Baird et al., 2012).  This may explain 
the some of the disparity between other proxy measures of muscle damage and the 
CK response.  Though the human CK response to exercise has not been fully 
elucidated, it is recognised as a good sign that EIMD has occurred.  CK in itself may 
not be the best measure of the magnitude of EIMD, and despite human variability, 
it can be a useful indicator of significant differences following manipulation of other 
variables, nutritional interventions for example.   
 
Creatine Kinase (CK) is involved in energy production, this enzyme catalyses 
adenosine di-phosphate (ADP) to adenosine tri-phosphate (ATP) in a reversible 
reaction (figure 3).  This reaction works alongside other energy systems to buffer 
energy production and thus meet increased energy requirements (Sherwood, 
2016).  In exercising muscles when energy demands are high, levels of CK in the 
blood rise exponentially (Kenney et al., 2012).  There is a general consensus that 
increases in CK after strenuous exercise peak within a week and then begin to 
return to baseline.  The magnitude and timing of the CK response however is 
dependent on the exercise modality and duration.  For example, the levels of CK for 
men subjected to exhaustive running peaked at 24 hours (170 IU/L), was falling at 
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48 hours and retuned to baseline by 72 hours (Oosthuyse & Bosch, 2017).  A 
slower and much more exaggerated response is apparent for resistance compared 
to endurance exercise.  When EIMD was induced in the biceps brachii of male 
participants by performing 50 maximal eccentric elbow flexion exercises, CK levels 
(7,684 IU/L) were still rising 96 hours after cessation of the exercise protocol 
(Tanabe et al., 2015).  The CK response also differs by limb. There is a greater CK 
response to eccentric arm exercises compared to eccentric leg exercises, with CK 
increases peaking on day three over 2000 IU/L for elbow flexion and below 500 
IU/L for knee extension (Saka et al., 2009).  Similar results have been reported for 
leg exercises more recently with CK peaks at 636IU/L after 100 maximal intensity 
drop jumps and 270IU/L for 64 barbell squats (Page, Swan, & Patterson, 2017; 
Romain et al., 2017).  There is clearly a more inflated CK response following 
exercise to upper limbs compared to lower limbs.  Interestingly, this more 
exaggerated response extends to other markers, specifically, DOMS and ROM (Saka 
et al., 2009).   
 
  
Creatine       Creatine Kinase     Creatine phosphate 
Figure 3. The Creatine Kinase reaction 
 
The CK response also differs by gender and is congruous in men but not in women, 
which may be due to menstrual phase (Oosthuyse & Bosch, 2017).  A correlation 
between pre exercise oestrogen and exercise-induced increases in CK levels has 
been previously reported (Carter, Dobridge, & Hackney, 2001).  It has been 
postulated that this is a result of the protective effect of oestrogen on exercise-
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induced muscle damage (Kendall & Eston, 2002).  Given gender differences in the 
physiological response to eccentric exercise and the role that oestrogen may play in 
CK activity, it is common to exclude female participants to limit inter-individual 
variations in response. Therefore, DOMS research is often gender specific and 
restricted to male participants (Pumpa, Fallon, Bensoussan, & Papalia, 2013; Ra et 
al., 2013; Vaile, Halson, Gill, & Dawson, 2008). 
 
Increases in CK activity can be a useful measure in exercise research when it 
correlates with other measures.  For example, a significant correlation has been 
demonstrated between CK and the reduction in muscle function, more specifically; 
torque (Hicks, Onambélé, Winwood, & Morse, 2016).  And further, the rise in blood 
CK has been shown to significantly correlate with DOMS pain following a bout of 
strenuous exercise (Ammar et al., 2016; J. Kim & Lee, 2015).   
 
It is clear that the CK timecourse variability is due to differences in the type, 
duration and intensity of each exercise protocol.  It has also been shown that inter-
individual variability is common and the CK response to exercise is biphasic and 
exaggerated in some individuals (Vyver & Myburgh, 2014).  That being said, the 
most consistently exaggerated response would seem to be in men with a protocol 
using eccentric exercises of the upper limbs.  It seems prudent therefore to use 
eccentric elbow flexion exercises with male participants in exercise biochemistry 
research. 
2.1.2.2 Interleukin 6 
Interleukin 6 (IL-6) is a cytokine released by t-cells and macrophages in the 
immune response.  This cell signalling protein can be synthesised within skeletal 
muscle and is therefore also known as a myokine.  High levels of circulating IL-6 
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are generated during exercise predominantly in fast twitch muscle fibres (Hiscock, 
Chan, Bisucci, Darby, & Febbraio, 2004).  The increases in muscle generated IL-6 
following a bout of exercise are dependent on the type, duration and intensity of 
that exercise (Morettini, Palumbo, Sacchetti, Castiglione, & Mazzà, 2017).  And 
further, exercise-induced increases in IL-6 are associated with the symptoms of 
DOMS (MacIntyre, Sorichter, Mair, Berg, & McKenzie, 2001).  
2.1.2.3 Swelling 
EIMD causes inflammation which usually manifests in a measurable swelling of the 
muscles (Felipe Damas et al., 2016).   The swelling can be quantified using a 
constant-tension measuring tape to determine the limb circumference, at baseline 
and at other timepoints after exercise when the inflammation is at or near its peak.  
In this way, the change in limb girth can then be used as an indicator of increased 
inflammation (Plattner et al., 2014; Ra et al., 2013).  Following an eccentric elbow 
flexion protocol, significant increases of upper arm circumference in the magnitude 
of 9% have been recorded (Howell et al., 1993). More recently a cluster analysis 
looking at high, moderate and low responders to EIMD after elbow flexion recorded 
increases of 3%, 6% and 7% respectively (F. Damas et al., 2016). 
 
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a class of pain relieving drugs 
that reduce inflammation.  The efficacy of NSAIDs in reducing the pain of DOMS is 
equivocal and where evidence exists, the effect size is small to medium (Morelli et 
al., 2018).  While NSAIDs do very little to reduce DOMS, they do interfere with the 
biochemical response to exercise (Urso, 2013).  Most notably, NSAIDs inhibit 
swelling caused by exercise-induced inflammation and have a negative impact on 
the repair and adaptation process (Ziltener, Leal, & Fournier, 2010).  Interestingly, 
inhibiting the inflammatory response to EIMD with NSAID’s in turn reduces other 
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biomarkers, CK for example (Morelli et al., 2018).  The magnitude of the response 
to these drugs in skeletal muscle is also dependent on the individual drug 
administered, timing and dose (Connolly, Sayers, & McHugh, 2003).  Without 
clarity on the effect of NSAIDs on DOMS pain, swelling and CK responses, for the 
purposes of the present study, NSAID use was restricted.  
2.1.2.4 Range of Motion 
The movement potential of the elbow joint can be determined using a goniometer 
to measure the number of degrees between full flexion and full extension.  The 
normal range of motion (ROM) for the elbow joint in men has been reported as 
144.6⁰ (Soucie et al., 2011).  Following prolonged unaccustomed eccentric exercise 
of the biceps brachii, the ROM of the elbow joint decreases due to swelling and 
DOMS pain.  Reductions in ROM have been recorded in the magnitude of -7⁰ and -
20⁰ following 24 and 50 maximal eccentric contractions respectively (O'Fallon et al., 
2012; Tanabe et al., 2015).   
2.1.3 Endocannabinoids 
Exercise in itself has been shown to have analgesic affects, reducing pain 
sensitivity.  Recently, endocannabinoids have been shown in animal models to have 
exercise-induced nociception capabilities (Galdino et al., 2014).  Suggesting that 
endocannabinoids have a role to play in exercise-induced analgesia in humans. 
Certainly, there appears to be some ‘cross-talk’ between exercise and the 
endocannabinoid system (ECS).  It is likely that the ECS mediates some of the 
effects of exercise and that exercise has a modulatory effect on the ECS 
(Tantimonaco et al., 2014).  For example, increased concentrations of AEA in the 
blood were reported after jogging or running on a treadmill compared to walking.  
And further, significantly greater increases in AEA were recorded at higher exercise 
intensities (Raichlen, Foster, Seillier, Giuffrida, & Gerdeman, 2013).  The pain 
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relieving, antinociceptive effects of the endocannabinoid AEA was documented two 
decades ago (Piomelli et al., 1998).  Taken together, it seems reasonable to 
assume that circulating levels of endocannabinoids have a bearing on pain 
perception after a bout of exercise. 
2.1.4 Summary 
Experimentally, physiological responses to exercise vary and do not consistently 
correlate with the level of exercise performed.  This may in part be due to the 
nature of varying exercise protocols and differing equipment use in randomised 
controlled trials.  Minor disparity in study methods and high variability in the human 
response mean that it is a challenge to compare intervention studies.  
There is a need for a standardised exercise protocol where there are expected 
outcomes for EIMD biomarkers and other variables such as nutritional interventions 
can be tested.  An evidence based exercise protocol that consistently induces 
measurable changes in the biomarkers associated with DOMS can be used to test 
DOMS intervention strategies.   
 
2.1.5 Aims 
To determine the optimum level of exercise to produce a physiological response 
that generates the greatest measurable changes in biomarkers of DOMS.  To design 
an evidence based protocol that can consistently induce DOMS for experimentally 
testing nutritional interventions.  
2.1.6 Hypothesis  
H0: There is no significant difference in biomarkers of DOMS in the biceps brachii 
induced by 48, 60 and 72 maximal eccentric repetitions of elbow flexion in men.    
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 Materials and Methods  
2.2.1 Participant Volunteers 
A convenience sample of volunteers were recruited though presentations, emails, 
flyers and word of mouth.  Following an expression of interest, volunteers were 
screened for eligibility.  Participants were ineligible to take part if they: were taking 
anticoagulant or anti-inflammatory medications; had type 2 diabetes; or had 
muscle/joint disorders of the upper body.  These exclusion criteria and details of 
the study were provided by verbal briefings and participant information sheets 
(Appendix 1).  Participants were fully informed of procedures and risks before 
providing written informed consent (Appendix 2).  Ethical approval was granted by 
the University of Huddersfield, Human and Health Sciences, School Research Ethics 
Panel (SREP). This study was carried out in accordance with the declaration of 
Helsinki (WMA, 2013). 
 
A total of 28 male university staff and students volunteered to participate in the 
DOMS protocol development.  Previous studies have reported differences in 
baseline measures and the magnitude of the biological response to exercise 
between genders (2 x citations). To minimise inter-individual variability, the 
present study used only male volunteers.  Volunteers were randomly assigned into 
one of three groups using a random number generator (www.graphpad.com).  
Height and weight measurements were self-reported or measured using a Seca 213 
portable stadiometer (Seca GMBH) (Figure 4) and the Salter compact analyser scale 
(Salter Housewares Ltd).  
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Figure 4. Seca Stadiometer. 
2.2.2 Experimental Design 
This study utilised a randomised independent group design.  Participants attended 
the Exercise Physiology Laboratory at the University of Huddersfield to perform an 
eccentric exercise intervention on an isokinetic dynamometer (Cybex, USA) (figure 
5).  Biomarkers (including DOMS scores) were taken at three time points: before 
the exercise intervention (time point A), after exercise intervention (time point B) 
and at follow up 48 hours later (time point C) (figure 1).  
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Figure 5 Overview of experimental design.  The exercise intervention to induce 
DOMS was performed immediately following baseline biomarker measurements 
taken at time point A.  Biomarker measurements were then repeated at time points 
B and C.  Measurements recorded at each timepoint: upper arm circumference 
(UAC), range of motion (ROM) of the exercised arm, a recording of pain (VAS) in 
the biceps brachii and blood sampling took place.   
2.2.3 Pilot 
Three participants were invited to take part in the DOMS protocol pilot to assess 
feasibility and timing requirements for blood sampling, analysis and the exercise 
intervention.   
2.2.4 Health Screening 
Participants were asked to complete a Health Questionnaire (Appendix 3), to 
provide background information and assess each participant for inclusion.  The 
Health Questionnaire included questions about dietary and lifestyle habits that may 
interfere with biomarker results. 
2.2.5 Dietary, exercise and drug Restrictions 
Participants restricted exercise, the use of over-the-counter pain relievers, and 
aspects of diet during the experimental phase.  The experimental phase began two 
days prior to the exercise intervention and finished after the follow up (48 hour) 
blood samples had been taken. Participants desisted from exercise throughout the 
four-day experimental period, and did not eat or drink anything except water for 
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the two hours prior to each blood sampling appointment.  Participant were 
requested to do without over-the-counter pain relievers during the experimental 
phase where possible, and report use. 
2.2.6 Eccentric Exercise Intervention 
The exercise intervention was performed on a Cybex NORM isokinetic dynamometer 
(Cybex, USA) in an Exercise Physiology Laboratory at the University of Huddersfield 
(figure 6).  All tests were carried out on the non-dominant arm, the dominant arm 
was defined as the writing arm.  The exercise intervention required participants to 
adopt the supine position and the elbow joint was aligned with the axis of rotation 
of the dynamometer.  The length of lever arm was adjusted to provide a 
comfortable grip.  Anatomical zero was set, and a range of motion restricted to 10° 
from anatomical zero through to 130° of elbow extension (120° ROM).  
Familiarisation with the dynamometer equipment consisted of submaximal elbow 
flexion exercises, and an explanation of the Humac Norm on screen graph. 
Participants then performed sets of 12 maximal voluntary eccentric contractions at 
600/s with 1-min rest periods between sets.  Following each contraction, the 
dynamometer arm passively reset allowing a 2s rest between contractions. To 
ensure maximal contractions, participants were verbally encouraged to maximally 
resit the downward action of the dynamometer arm throughout the entire 1200 
range of motion (ROM). Participants were given visual feedback via the 
dynamometer screen graph, which has been shown to have a positive effect on 
effort (Baltzopoulos, Williams, & Brodie, 1991). 
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Figure 6.  Cybex NORM dynomometer 
2.2.7 Biomarkers 
Biomarkers were recorded on a participant testing record (Appendix 4) 
2.2.7.1 Perceived Muscle Soreness 
A Likert-like visual analogue scale (VAS) was used to evaluate perceived muscle 
soreness.  A 10cm sliding scale ruler with 0 at one end and 10 at the other, 0 
representing ‘no pain’ and 10 representing ‘extremely painful’.  Participants were 
asked to move the slide on the ruler to the corresponding level of pain in the bicep 
brachii when the elbow joint was passively extended and flexed.  Scoring pain on a 
visual analogue scale is widely used method to determine pain intensity (Lau et al., 
2015; Matsumura et al., 2015). 
2.2.7.2 Upper Arm Circumference 
The upper arm circumference (UAC) provided a measure of swelling within the 
biceps brachii, changes in the UAC was used as a marker of inflammation.  The 
participant stood with a relaxed arm while the mid-belly of the biceps brachii was 
measured in millimetres (mm) using a constant-tension measuring tape (brand).   
2.2.7.3 Range of Motion 
The range of motion (ROM) of the elbow joint was quantified by taking two joint 
angle measurements using a standard goniometer.  The flexed joint angle was 
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taken when each participant attempted to fully flex the elbow joint by touching the 
shoulder on the same side.  The extended joint angle taken with the participant’s 
arm proximal to the body and maximally extended.  The ROM was calculated as the 
extended joint angle minus the flexed joint angle as previously described (H.-L. 
Chen et al., 2012). 
2.2.8 Blood Biomarkers; Sampling & Analysis 
Blood biomarkers were measured before the exercise intervention (at baseline); 
immediately after the exercise intervention; and finally 48 hours later.  Standard 
venepuncture techniques and fingerprick techniques were used to collect blood 
samples at the three time points: timepoint A (immediately before exercise), 
timepoint B (immediately after exercise) and timepoint C (48 hours after exercise). 
Finger-prick capillary blood samples for the assessment of CK were obtained using 
ACCU-CHEK Plus (Roche Diagnostics USA) disposable lancets.  Capillary blood was 
then collected into 30µl capillary action micropipettes for analysis.   Venous blood 
samples were obtained from an antecubital vein using the vacutainer system (BD 
Vacutainer).  Each 6ml vacutainer tube was inverted 8 times to mix the 
anticoagulant ethylenediaminetetraacetic acid (EDTA) with the sample.  Within one 
hour of collection, the sample was centrifuged (1,000 x g for 10 mins) to separate 
cells from plasma.  The supernatant plasma was pipetted into 1.5ml 
microcentrifuge tubes for storage until analysis for IL-6, AEA, and 2-AG.  
Participants were given an aftercare sheet (Appendix 5) 
2.2.8.1 Equipment list for blood sampling (figures 7 & 8) 
 
Finger prick sampling: 
Paper towels 
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Alcohol hand gel 
70% Alcohol Pre-injection swabs (Medisave) 
Safe-T-Pro plus lancets (Accu-Check) 
Sharps Bin 
30µl capillary action pipettes 
Cotton Wool 
Plasters 
 
Venepuncture: 
Paper Towels 
Alcohol hand gel 
70% Alcohol Pre-injection swabs (Medisave) 
Tourniquet 
Medical Gloves (find Name) 
6ml EDTA venepuncture tubes 
Vacutainer single use holders 
21g Vacutainer Eclipse needles 
Cotton Wool 
Sharps Bin 
Cotton Gauze 
Non-allergy Medical Tape 
Eppendorf MiniSpin Microcentrifuge (figure 7)  
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Figure 7. Eppendorf Mini Spin Microcentrifuge 
 
 
Figure 8. Blood sampling table layout and equipment.  
2.2.8.2 Creatine Kinase 
The 30µl sample of capillary blood was applied to the Roche Creatine Kinase (CK) 
test strip and inserted into the clinical analyser immediately after collection.   The 
Reflotron clinical analyser (Roche Diagnostics USA) (figure 9) then measured CK 
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within detection limits of 24-1400 International Units (U/L). 
 
Figure 9.  Reflotron Plus (Roche Diagnostics USA) 
2.2.8.3 Interleukin-6 
The analysis of plasma levels of interleukin 6 (IL-6) was then determined using a 
commercially available enzyme linked immunosorbent assay (ELISA) kit (Biolegend 
Inc, USA).  All ELISA analyses were performed according to the manufacturers 
recommended instructions and in duplicate.  Sample concentrations were 
determined relative to the standard solutions provided in the ELISA kit.   
Procedure for Human IL-6 Enzyme Linked Immunosorbent Assay (ELISA) 
 
Equipment and solutions for Biolegend Human IL-6 ELISA (figure 10) 
Microplate Reader 
Microcentrifuge (Eppendorf UK) 
Adjustable pipettes 
Test tubes 
2ml Microcentrifuge Tubes (Eppendorf UK) 
Wash Bottle 
Plate sealers 
Paper towels 
Human IL-6 ELISA Capture Antibody (200X) 
68 
  
 
Human IL-6 ELISA Detection Antibody (200X) 
Human IL-6 Standard  
Avedin-HRP (1000X) 
Substrate solution A 
Substrate solution B 
Coating Buffer A (5X) 
Coating Buffer B (5X) 
96 Microwell Plates (Nunc™) 
Phosphate Buffered Saline (PBS) 
Wash Buffer 
Stop Solution 
Deionised water 
 
 
  
Figure 10.  ELISA kit and solutions 
 
Laboratory procedure for Human IL-6 Enzyme Linked Immunosorbent 
Assay (ELISA) 
1. Coating buffer A (5X) was diluted to 1X with deionised water. 
2. Capture antibody was diluted to 1:200 with 1X coating buffer A. 
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3. The PBS solution was made up by adding 1 tablet per 200ml of deionised 
water and stirred using a magnetic stir plate and magnetic stirrer until clear 
with no particles. 
4. Assay diluent A (5X) was diluted to 1X with PBS. 
5. The IL-6 standard solution was reconstituted with 1X assay diluent A, then 
allowed to stand for 15 minutes and gently agitated. 
6. Standard solutions were prepared as follows:  A six two-fold serial dilution of 
500pg/ml top standard with 1X assay diluent A gave concentrations of – 
500pg/ml, 250pg/ml, 125pg/ml, 62.5pg/ml, 31.3pg/ml, 15.6pg/ml and 
7.8pg/ml.  1X assay diluent A served as a ‘blank well’ zero concentration 
standard (Figure 11). 
 
 
Figure 11.  Serial Dilution of Human IL-6 standard solutions. 
 
7. IL-6 detection antibody was diluted 1:200 with 1X assay diluent A. 
8. Avidin HRP was diluted 1:1,000 in 1X assay diluent A. 
9. One day prior to running the ELISA the plates were pre-coat with the capture 
antibody solution (see 2. above).  Each well of the 96-well plate was 
inoculated with 100µl of capture antibody solution.  The plate was then 
sealed and incubated overnight (16-18hours) between 2ºC and 8ºC. 
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10.Samples were removed from the freezer (-18ºC) and refrigerated overnight 
with the plate. 
11.All reagents were brought to room temperature before being used. 
12.The plate was washed 4 times by pipetting 300µl of wash buffer per well, 
emptied, then blotted by firmly tapping the plate upside down on an 
absorbent paper towel (subsequent washes were performed in the same 
way). 
13.Background and non-specific binding was reduced by ‘blocking’ the plate with 
200µl of assay diluent A per well and shaken on a shaker plate for 1hour at 
room temperature (all subsequent incubation with shaking was performed in 
this way) 
14.The plate was washed 4 times with wash buffer. 
15.100µl of each standard solution (7 + blank) or plasma samples was pipetted 
into the wells in duplicate (figure 12).  The plate was then sealed and 
incubated with shaking for two hours. 
Figure 12.  Samples and standards preparation 
 
16.The plate was washed 4 times with wash buffer. 
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17.100µl of diluted detection antibody solution (see 7. above) was pipetted into 
each well and then the plate was sealed and incubated with shaking for 1 
hour. 
18.The plate was washed 4 times with wash buffer. 
19.100µl of Avidin HRP solution (see 8. above) was pipetted into each well and 
then the plate was sealed and incubated with shaking for 30 minutes. 
20.The plate was washed 5 times with wash buffer.  For this wash cycle the 
wash buffer was allowed to sit in the wells for 1 minute before blotting each 
wash to help minimise background. 
21.TMB substrate solution was made up by mixing equal volumes of Substrate 
solution A & B and used immediately.  100µl TMB substrate solution was 
pipetted into each well then the plate was incubated in the dark for 15 
minutes until cells began to turn blue. 
22.The reaction was stopped by adding 100µl of stop solution to each well, 
positive cells now turned from blue to yellow. 
23.Immediately following the addition of the stop solution, the absorbance was 
read at 450mn using a microplate reader (figure 13).   
 
 
Figure 13.  Microplate reader 
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2.2.8.4 Anandamide 
Circulating levels of Anandamide (AEA) was determined using HPLC triple 
quadrupole mass spectrometry (HPLC-QQQ-MS).   Following venepuncture, blood 
samples were centrifuged and the supernatant plasma was removed, pipetted into 
1.5ml aliquots and stored at -80ºC until analysis.  Levels of Anandamide was 
established using a validated method for human plasma outlined by Zoerner et al. 
(2012).   
Laboratory procedure for HPLC-QQQ mass spectrometry 
Equipment and solutions for HPLC-QQQ-MS  
Agilent 1290 Infinity II UPLC machine 
Agilent 6470 Triple Quadrupole LC/MS system (figure 14) 
Zorbax Eclipse Plus C18 HPLC column (Agilent Technologies) 
TurboVap Evaporator (Biotage EU) 
Refrigerated Centrifuge 
Auto pipettes 
10ml volumetric flask 
100ml volumetric flask 
Test tubes 
HPLC vials 
HPLC inserts 
2ml Microcentrifuge Tubes (Eppendorf UK) 
Ice bowl 
Water bath Sonicator 
LCMS grade Acetonitrile (Fisher Scientific)  
HPLC grade Toluene (Fisher Scientific) 
HPLC grade Formic Acid 
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LCMS grade 3:1 Ethenol:water (Fisher Scientific) 
A 50,000ppm solution containing 10 mg of AEA in 200µl using ethanol as a 
solvent (Caymen Chemicals).   
A 1,000ppm solution of 500µg of D4-AEA in 50 µl using ethanol as a solvent 
(Caymen Chemicals). 
 
 
 
Figure 14.  Agilent 1290 Infinity II UPLC and Agilent 6470 Triple Quadrupole LC/MS 
system. 
 
Sample and standards preparation 
1. A 1ppm internal standard solution of D4-AEA was prepared by adding 10µl of 
the D4-AEA standard to a 10ml volumetric flask and making to volume with 
acetonitrile. 
2. A 32 ppb internal standard solution of D4-AEA was prepared by adding 320µl 
of the 1ppm standard to a 10 ml volumetric flask and making to volume with 
acetonitrile. 
3. A 100ppm internal standard solution of AEA solution was prepared by adding 
20µl of the 50,000ppm standard to a 100 ml volumetric flask and making to 
volume with acetonitrile. 
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4. Samples were removed from the freezer and allowed to thaw at room 
temperature before 1ml of plasma was pipetted into 2ml microcentrifuge 
tubes (Eppendorf). 
5. 10µl of 32ppp standard D4-AEA solution was added to each sample with 1ml 
of toluene (Fisher Scientific). 
6. The Sample solutions were sonicated for 30 minutes in a water bath then 
centrifuged for 5 minutes at 12,000rpm. 
7. The organic phase was pipetted out and transferred to a test tube.  The 
samples were then evaporated (TurboVap) under Nitrogen. 
8. 100µl of 3:1 menthanol:water was added to each sample and sonicated for a 
further 5 minutes in a water bath. 
9. Final sample solutions were transferred to 200µl HPLC vials and analysed by 
HPLC triple quadrupole mass spectrometry (figure 14). 3:1 Methonol:water 
served as a blank. 
2.2.9 Variables 
The independent variable (IV) consisted of three levels of exercise represented as 
different numbers of repetitions of eccentric elbow flexion exercises: 48 repetitions 
(48ECC), 60 repetitions (60ECC) and 72 repetitions (72ECC).  Dependent variables 
comprised of the subsequently recorded biomarkers at time point A (before 
exercise), time point B (after exercise), and time point C (48 hours later).  
Dependant variables (DV’s) were as follows: DOMS, UAC, ROM, CK, IL-6, and AEA. 
2.2.10 Statistical methods 
Statistical analysis was performed using SPSS version 24 (IBM Corp., USA) with the 
significance level set at p>0.05 for all analyses.  To determine normality, these 
data were assessed both visually (histograms) and statistically using the Shapiro-
Wilk test for normality.  Assumptions of homogeneity of variance were tested using 
75 
  
 
the Levene’s test for equality of variances.  Central tendencies and measures of 
spread were derived for the DV’s and expressed as mean ± standard deviation (SD) 
or median with interquartile range (IQR).   
 
Parametric tests were used on DOMS and UAC data.  Significant main time effects 
for DOMS, and UAC was assessed using paired sample t tests.  To detect significant 
differences between conditions (48, 60, 72 repetitions) at baseline and at 48 hours, 
data was compared using a one-way between groups analysis of variance (ANOVA).   
Where a significant experimental effect existed, Bonferroni’s post hoc test was used 
to establish specific group differences.  The effect of time was assessed within each 
condition using paired sample t tests, a within group comparison between baseline 
and 48 hours was performed for each variable.  A one-way between groups ANOVA 
was then used to assess the time x condition effect of the level of exercise (48, 60 
or 72 repetitions) on the change in DOMS and UAC over the 48 hour period.   
 
For non-parametric CK, IL-6, ROM and AEA data the following tests were used to 
assess; baseline differences (Kruskal-Wallis test), main time effect (wilcoxen 
Signed Rank test) and group x time effect (Kruskal-Wallis test).  Where significant 
differences were identified, 95% confidence intervals were used to present the 
estimation of mean differences.   
 
A Pearson product moment correlation was used to assess the relationship between 
the 48 hour changes in DOMS and UAC scores.  Finally, a Spearmans Rho 
correlation was used to assess the relationships between 48 hour changes in DOMS, 
IL-6, ROM and AEA. 
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  Results 
2.3.1 Study population 
Twenty-eight volunteers were assessed for eligibility before taking part in the 
study.  Of these volunteers, one reported to the physiology laboratory after 
inadvertently taking part in an additional bout of exercise and was excluded from 
further participation in the study.  Two participants had implausibly high CK at 
baseline and were excluded from further analysis.  Also, full blood samples were 
not possible for two participants and were therefore excluded from blood biomarker 
analysis, but included in all other measures.  A total of 25 volunteers (31.6 ± 13.2 
years; 83.2 ± 13.0 kg; 179.0 ±6.9 cm) completed the experimental protocol and 
were included for statistical analysis. 
2.3.2 Indicators of Muscle Damage 
There were no significant differences between groups for any baseline measures.  
All three exercise protocols (4, 5 and 6 sets) were sufficient to induce significant 
changes in muscle damage biomarkers.  The data for DOMS and UAC followed a 
normal distribution.  The data for ROM, CK, IL-6 and AEA did not follow a normal 
distribution both visually (histogram) and statistically (Shapiro-Wilk), non-
parametric tests were therefore used for these data.  The data for DOMS and ROM 
returned a non-significant result for the Shapiro Wilk test, indicating a normal 
distribution of these data.  A significant time effect between baseline measures and 
48 hours were found for DOMS (p=0.000), upper arm circumference (p=0.001), 
ROM (p=0.000), CK (p=0.004), IL-6 (p=0.007).  Table 1 shows mean and median 
values for biomarkers for muscle damage; DOMS, UAC, ROM, CK activity and 
circulating IL-6.  
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Table 1.  Biomarkers of Exercise-induced Muscle Damage 
 
Biomarker 
Time point A 
Baseline 
Time point B 
After exercise 
Time point C 
48 hours 
Soreness (VAS 0-10) 0.8 ± 0.3 2.6 ± 1.7* 4.7 ± 2.2*** 
Creatine Kinase (IU/L) 124.0 (206.0) 141.5 (184.5) 254.0 (503.0)** 
Interleukin 6 (pg/ml) 8.2 (4.4) - 10.86 (7.8)** 
Upper Arm Circ (cm) 32.7 ± 3.0 33.3 ± 3.0* 33.2 ± 3.2** 
Range of motion (Degrees) 145.0 (17.0) 132.0 (15.0)* 133.0 (11.0)*** 
    Mean (SD)/median (IQR) values at baseline, immediately after and 48 hours after exercise for all participants 
(n=25).  Asterisk superscript *, ** and *** denotes a significant difference relative to baseline p<0.05, p<0.01and 
p<0.001 respectively.  
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2.3.2.1 Perceived Muscle Soreness 
There was a significant main time effect on DOMS ratings following the exercise 
protocol, all participants reported an increase in soreness at 48 hours (p=0.000) 
(table 1).  Ratings of perceived muscle soreness did not differ between the three 
groups at baseline (p=0.685), immediately following the exercise protocol 
(p=0.195) or 48 hours after exercise (p=0.766).  At 48 hours, the greatest changes 
in DOMS scores were recorded for the 60 repetition group (5.0 ± 2.1) compared to 
48 repetitions (4.2 ± 2.1) and 72 repetitions (4.6 ± 2.6) (Figure 15).  However, no 
significant differences in soreness ratings were found between groups after 48 
hours (p=0.766) (Table 2). 
  
Figure 15. Increases in DOMS pain scores relative to baseline by exercise volume 
(displayed as a mean); 48 eccentric elbow contraction, 60 eccentric elbow 
contractions and 72 eccentric elbow contractions.  No significant differences 
between groups were found (p=0.766). Asterisk superscript ** and *** denotes a 
significant difference relative to baseline within a group p<0.01 and p<0.001 
respectively.  
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2.3.2.2 Creatine Kinase 
There was a significant main time effect at 48 hours (p=0.004) compared to 
baseline (table 1).  CK activity did not differ between the three groups at baseline 
(p=0.494), immediately following the exercise protocol (p=0.405), or at 48 hours 
(p=0.632).  There was no group x time interaction (p=0.829) (table 2).  Significant 
increases in CK concentrations were recorded in the 48 (p=0.028) repetition group 
only.  However, increases in CK in the 60 repetition group neared significance 
(p=0.069).  There was no significant increase in CK for the 72 repetition group 
(p=0.310).  Median (IQR) increases in CK at 48 hours were highest for the 48 
repetition group of 61.5 (651.4) compared to the 60 repetition group of 55.5 
(476.7) and 72 repetitions 34.0 (218.0) (figure 16).  
 
  
Figure 16.  Change in Creatine Kinase activity relative to baseline by exercise 
volume; 48 eccentric elbow contraction, 60 eccentric elbow contractions and 72 
eccentric elbow contractions (displayed as a median).  No significant differences 
between groups were found (p=0.829).  *Significantly different to baseline p<0.05. 
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Table 2. Biomarker outcomes according to number of repetitions of elbow flexion.  Displayed as mean (SD) or median (IQR). 
   
 
         
  
48 Reps (n=9)  60 Reps (n=9)  72 Reps (n=7) 
 between 
groups; p 
  Baseline 48 hours  Baseline 48 hours  Baseline 48 hours   
            
DOMS (VAS 0-10)  0.1 ± 0.3 4.3 ± 2.2***  0.1 ± 0.3 5.0 ± 2.1***  0.00 ± 0.00 4.6 ± 2.6**  p=0.766 
            
UAC (cm)  33.4 ± 2.0 34.0 ± 2.4**  33.6 ± 3.9 34.2 ± 3.7**  30.7 ± 2.2 30.7 ± 2.1  p=0.069 
            
ROM (Degrees)  145.0 (22.0) 138.0 (21.0)  137.0 (19.0) 129.0 (29.0)**  146.0 (18.0) 136.0 (11.0)**  p=0.111 
            
CK (IU/L)    124.0 (61.0) 189.0 (737.0)**  158.5 (444.5) 447.0 (867.3)  121.0 ± 421.0 246.0 (393.0)  p=0.829 
            
IL-6 (IU/L)  9.5 (7.5) 15.1 (21.7)*  9.6 (6.7) 10.9 (5.4)  5.4 (2.5) 9.0 (7.4)  p=0.247 
            
            
Asterisk superscript *, ** and *** denotes a significant difference relative to baseline within a group p<0.05, p<0.01 and p<0.001 respectively.  Significance 
assessed by ANOVA for Soreness, and UAC. Significance assessed for CK, IL-6 and ROM with the Kruskal-Wallis Test.
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2.3.2.3 Interleukin-6 
There was a significant main time effect at 48 hours (P=0.006) compared to 
baseline (table 1).  There was no significant group x time interaction for the change 
in circulating IL-6 (p=0.247) (table 2).   After 48 hours, a significant time effect 
was evident for 4 sets only (p=0.021).  After 48 hours, there was no significant 
time effect for 5 sets (p=0.484) or 6 sets (p=0.080) (figure 17).  
  
Figure 17. Change in Interleukin-6 levels relative to baseline by exercise 
(displayed as a median); 48 eccentric elbow contraction, 60 eccentric elbow 
contractions and 72 eccentric elbow contractions.  No significant differences 
between groups were found (p=0.247).  *Significantly different to baseline p<0.05. 
 
2.3.2.4 Upper Arm Circumference  
Baseline data did not differ between groups.  Homogeneity of variance was violated 
at baseline according to Levene’s test (p=0.028).  However, using more robust 
tests of equality of means, Welch (p=0.066) and Brown-Forsythe (p=0.111), 
homogeneity of variance can be assumed.  There was a significant main time effect 
immediately after the exercise protocol (p=0.000) and at 48 hours (p=0.001) 
compared to baseline (table 1).  More specifically within each group, significant 
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time effect existed from baseline to 48 hours for 48 and 60 repetitions only 
(p=0.005 and p=0.008 respectively).  There was no significant increase in upper 
arm circumference 48 hours after the exercise protocol where 72 repetitions 
(p=0.914) were performed (Table 2).  There was no significant group x time 
interaction, however, this did approach significance (p=0.069).  Mean changes in 
UAC were higher for 48 repetitions (0.69 ± 0.53) and 60 repetitions (0.61 ± 0.53) 
compared to 72 repetitions (0.03 ± 0.67) (figure 18).   
  
Figure 18. Changes in upper arm circumference (UAC) relative to baseline by 
exercise volume (displayed as a mean); 48 eccentric elbow contraction, 60 
eccentric elbow contractions and 72 eccentric elbow contractions.  No significant 
differences between groups were found (p=0.069).  Asterisk superscript * and ** 
denotes a significant difference relative to baseline within a group p<0.05 and 
p<0.01 respectively.   
 
2.3.2.5 Range of Motion  
There was a significant main time effect immediately after the exercise protocol 
(p=0.000) and after 48 hours (p=0.000) compared to baseline (table 1).  This was 
represented by a significant reduction of 8˚ in the range of motion of the elbow 
joint over 48 hours.  There existed a significant time effect from baseline to 48 
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hours for the 60 repetition group (p=0.013) and 72 repetition group (p=0.018), but 
not 48 repetition group (p=0.262).  However, there was no significant group x time 
interaction (p=0.111) found.  Within the individual groups, there was a 48 hour 
ROM reduction of 3˚ in the 48 repetition group, 12˚ in the 60 repetition group and 
8˚ in the 72 repetition group (figure 19).   
  
Figure 19.  Decreases in range of motion (ROM) relative to baseline by exercise 
volume (displayed as a mean); 48 eccentric elbow flexion contraction, 60 eccentric 
elbow flexion contractions and 72 eccentric elbow flexion contractions.  No 
significant differences between groups were found (p=0.111).  Significantly 
different to baseline p<0.05*. 
 
2.3.3 Anandamide 
Anandamide (AEA) data did not follow a normal distribution, therefore non-
parametric tests were used to evaluate differences of this variable. There was no 
statistical difference between the groups at baseline (p=0.319), or at 48 hours 
(p=0.435).   A reduction in circulating AEA was evident with a significant main time 
effect over 48 hours (p=0.033).   Median 48 hours decreases in AEA were as 
follows: 48 repetition group -0.54 (n=6), 60 repetition group -1.67 (n=3), 72 
repetition group -1.32 (n=2) (figure 20).  However, these reductions did not reach 
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statistical significance for any of the three groups.  There was no significant group x 
time interaction (p=0.149).  Due to QQQ mass spectrometry issues, the AEA data 
results were reduced to between 2 and 6 data points for each analysis.  Therefore, 
the endocannabinoid results should be interpreted with caution. 
  
Figure 20. Changes in Anandamide (AEA) concentration relative to baseline by 
exercise volume (displayed as a median); 48 eccentric elbow contraction, 60 
eccentric elbow contractions and 72 eccentric elbow contractions.  No significant 
differences between groups were found (p=0.149).  Anandamide concentrations did 
not significantly change from baseline for any level of exercise volume.   
 
2.3.4 Correlations between variables 
Significant negative Spearman’s Rho correlations were observed between; the 48-
hour decrease in increase in DOMS and the decrease in ROM (r=-0.425; p=0.034); 
and the increase in circulating CK levels and decrease in ROM (r=-0.427; p=0.037).  
A significant positive Spearman’s Rho correlation between the increase in DOMS 
and the increase in CK (r=0.436; p=0.033).   
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 Discussion 
2.4.1 DOMS induction 
The present study evaluated the effects of three levels of exercise on DOMS related 
indices of muscle damage 48 hours after an acute bout of exercise.   The exercise 
protocol was sufficient to induce DOMS pain in the biceps brachii, and increases in 
the blood markers CK and IL-6 confirmed EIMD.  The magnitude of post exercise 
alterations in the indices analysed were similar to those reported in other studies 
(Guilhem et al., 2013; Lau, Blazevich, Newton, Wu, & Nosaka, 2015b; Nosaka et 
al., 2002; Tanabe et al., 2015). 
2.4.2 Muscle soreness. 
Maximal voluntary contractions are unlikely to be maximal throughout a high 
number of repetitions.  From previous dynamometry research using a 10cm VAS to 
measure DOMS in the biceps brachii, it is apparent that a lower number of eccentric 
contractions usually, but not always, results in lower mean pain scores 48 hours 
later.  For example, 20 voluntary maximal eccentric contractions resulted in a mean 
soreness score of less than 3cm (Lima et al., 2017), and 40 repetitions resulted in 
4.5cm (Connolly et al., 2006).  This is broadly in line with 4.3cm (48 contractions) 
and 5.1cm (60 contractions) in the present study.  Conversely, a high DOMS score 
of 8.5cm have been recorded following a protocol involving a large number of 
maximal eccentric contractions of the biceps brachii (Jeon, Kang, Park, & Lee, 
2015).  However, in that case the exercises were performed to exhaustion, which 
would undoubtedly have increased the DOMS scores.  When a large number of 
maximal eccentric contractions are performed without reaching exhaustion, DOMS 
pain is less intense.  For example, performing 125 maximal eccentric elbow flexor 
exercises resulted in peak pain scores of less than 4cm (Plattner et al., 2014).  
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Given the large number of contractions, motivation to make each contraction 
maximal may have been compromised.  It has been shown that the perception of 
effort correlates with motor command during a contraction (de Morree, Klein, & 
Marcora, 2012).  The contractions in the present study were voluntary and 
therefore the strength of each contraction was dependent on the motivation and 
effort of each participant.  It is therefore possible that participants reduce effort to 
a manageable level knowing they were expected to repeat each maximal 
contraction many times.  Thus resulting in lower DOMS scores in the present study 
for the 72 contractions group (4.6cm) compared to the 60 contraction group 
(5.1cm).  It is likely that motivation to contract every repetition maximally was 
sustained at 60 repetitions but not 72 repetitions, leading to moderation of the 
increases in muscle damage indices including DOMS pain.  Based on the pain scores 
alone, the optimum number of repetitions to test an antioxidant intervention using 
the same protocol is 60. 
 
The length of time each contraction is sustained has a bearing on resulting 
soreness.  After 30 maximal eccentric contractions, a relatively high peak soreness 
on day two was recorded as 4cm (Ochi, Tsuchiya, & Nosaka, 2016).   Though only 
30 contractions were performed, each contraction lasting 3 seconds which likely 
increased the pain score for such a low number of contractions. This level of pain is 
broadly in line with that produced in the 48 contractions group in the present study 
where each contraction lasted 2 seconds.  When 30 contractions were performed 
with each contraction lasting 5 seconds the resulting mean DOMS score has been 
reported as almost 6cm.  Study participants were allowed a 3s rest between 
contractions which seems to have a bearing on DOMS intensity (Ra et al., 2013).  
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For example, the same 6cm DOMS score was reported after 50 contractions lasting 
only 1 second each, crucially, participants were allowed a 12s rest and reset 
between contractions compared to 3s above (Tanabe et al., 2015).  The relatively 
long rest period of 12s allowed for a ‘biochemical reset’, e.g. enabling the 
replenishment of ATP and phosphocreatine and removal of lactate.  Without this 
‘metabolic reset’ the ability to sustain high force muscular contractions is 
compromised (Grgic, Schoenfeld, Skrepnik, Davies, & Mikulic, 2017).  As expected 
in the present study, the relatively short 2 second rest period and 2 second 
contraction time resulted in slightly lower DOMS scores than those above.  
 
While significant statistical differences between groups is important, in DOMS 
research where small sample sizes are common, considering the magnitude of the 
effect can be more useful in evaluating the data.  In the present study there was no 
statistical difference between the DOMS scores for the three groups.  However, the 
highest mean DOMS score of 5.1cm was recorded in the 60 repetition group.   This 
DOMS score is in agreement with previous work for 60 repetitions of maximal 
eccentric elbow flexion exercises, 5.2cm (Guilhem et al., 2013) and 4.8cm (Lau et 
al., 2015b).  Given that the 72 repetition group had a lower DOMS score than the 
60 repetition group, 60 repetitions is an adequate number to test an antioxidant 
intervention. 
2.4.3 Creatine Kinase 
In the present study, the greatest increases in CK enzyme activity were seen 
following 48 repetitions (306.3 IU/L), with a lower response after 60 repetitions 
(447 IU/L) and the lowest response after 72 repetitions (246 IU/L).  Similar 48hr 
responses have been recorded following maximal eccentric elbow flexion exercises 
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with CK increases in the magnitude of the present study (Howatson & van 
Someren, 2007; Matsumura et al., 2015; Newton et al., 2013).  In some cases a 
seemingly similar protocol brings about a more exaggerated CK response (Coratella 
& Bertinato, 2015; Ra et al., 2013). The CK results in the present study were a little 
lower than expected for 72 repetitions.  However, it is likely that CK was still rising 
at 48 hours, for example, CK was recorded as still increasing on day 5 after 42 
eccentric contractions of the elbow flexor (Shirato et al., 2016). In the present 
study, CK was likely to still be rising at 48 hours.  It is possible that the response 
was slower after 72 repetitions compared to less repetitions. In a less strenuous 
protocol using the same biceps brachii muscles, a less exaggerated and more 
delayed response occurs.  Eccentric contractions performed at 80% of the 
maximum isometric contraction torque, resulted in a peak in CK that did not occur 
until day five, 108 hours after cessation of exercise (Plattner et al., 2014).  For 
other types of contraction, isometric for example, the CK response can be absent 
altogether.  Following 50 isometric elbow flexion exercises, no significant time 
effect for CK was recorded.  Interestingly, in the same participants, when the 
biceps brachii muscles were electrically stimulated in the contralateral arm, CK 
levels were still rising at 96 hours in a similar response to Tanabe above (Jubeau et 
al., 2012).  The timecourse has been demonstrated using a cluster analysis 
(n=286) which showed that CK gradually rises in the days following maximal 
eccentric elbow flexion exercises and generally peaks on day 4.  Interestingly the 
cluster analysis also demonstrated clear evidence for high and low responders for 
increases in CK enzyme activity (F. Damas et al., 2016).  It is likely that there were 
high and low responders within the 25 participants in the present study.  It should 
also be noted that a relatively small group of participants performed 72 repetitions 
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(n=7).  And further, given that the CK response can be biphasic (Vyver & Myburgh, 
2014), and does not necessarily correlate well with exercise intensity (Malm et al., 
2000) recording CK at more than one timepoint would be advantageous. 
2.4.4 Interleukin 6 
A bout of maximal eccentric elbow flexion exercises does not usually significantly 
increase IL-6 concentrations (Guilhem et al., 2013; Tanabe et al., 2015).   
However, in contrast to previous work, the present study reported significant 
increases in IL-6 in the 48 repetition group (Guilhem et al., 2013; Trombold, 
Barnes, Critchley, & Coyle, 2010).  This is unusual for a bout of exercise with a 
relatively low metabolic cost compared to high metabolic cost activities such as 
running e.g. downhill running, half marathon or an ultramarathon, activities which 
significantly increase IL-6 concentrations (Arakawa et al., 2016; Vyver, 
Engelbrecht, Smith, & Myburgh, 2016).  Interestingly there were two peaks 
following the ultramarathon, one on day one and a second on day five (Arakawa et 
al., 2016).  Following a half marathon IL-6 peaked 60 minutes after exercise and 
had returned to baseline by 24hours and was still around baseline at 48 hours 
(Levers et al., 2016).    Compared to the lower metabolically costly maximal 
eccentric elbow flexion exercises, where there are no significant increases in IL-6 
over 48 hours; 30 contractions (Conceição et al., 2012), 40 contractions (Trombold 
et al., 2010) or 60 contraction (Guilhem et al., 2013).  Though not significant, 
levels of IL6 after 50 maximal eccentric contractions of the elbow flexor shows a 
trend upwards over a four day period, and was still rising on day four (Tanabe et 
al., 2015).  It is possible therefore, that participants in the 60 and 72 repetition 
groups had increases in IL-6 that occurred after 48 hours which were not captured.  
However, the follow up to 60 eccentric elbow flexion contractions in Guilhem et al. 
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(2013) was 14 days with no significant increases in IL-6 at any time point.  This 
suggests that the non-significant increases in IL-6 in the 60 and 72 repetition group 
was to be expected. 
2.4.5 Swelling 
It is likely that one or more elements of inflammation, with the corresponding 
muscle swelling, is responsible for the pain of DOMS.  In a DOMS affected muscle, 
pain sensitivity changes, measured by the electrical pain threshold (EPT), do not 
occur uniformly across the whole muscle structure.  When comparing the electrical 
pain threshold (EPT) of the skin, fascia and muscle tissue after eccentric 
contractions of the finger, the EPT was only significantly reduced in the fascia.  And 
further, that the pressure pain threshold (PPT) was reduced in fascia in a mirrored 
fashion with the increase in DOMS (Itoh, Okada, Kawakita, White, & Cummings, 
2004).  More recent evidence indicates that the same is true for the biceps brachii.  
Decreases in EPT have been shown to be significantly greater in fascia compared to 
muscle tissue in a DOMS affected biceps brachii.  It was concluded that the 
increased pain sensitivity in DOMS is associated with inflammation in the fascia 
rather than muscle fibres (Lau et al., 2015a).  This seems plausible given that 
nociceptors are sensitised by the inflammation caused by muscle damaging 
exercise (Ota et al., 2018) and the density of nociceptors in the fascia is higher 
than in muscle tissue (Andres, von Düring, Von During, & Schmidt, 1985).  In the 
present study there was a relatively small but significant increase in UAC, indicating 
that the eccentric contractions had elicited an inflammatory response in the biceps 
brachii, albeit a minor one.  It is likely that the swelling would have continued to 
increase over the subsequent 5-day period (Tanabe et al., 2015).  In the present 
study the inflammatory response and corresponding increases in UAC only occurred 
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in the 48 (0.69mm) and 60 (0.61mm) repetition groups and was not present after 
72 (0.03mm) repetitions.   These were unexpectedly low 48 hour increases in UAC 
compared to studies using similar protocols: 5mm after 50 repetitions (Tanabe et 
al., 2015), 8ml after 60 repetitions (Newton et al., 2013). 
2.4.6 Range of Motion 
As expected, the eccentric exercise protocol resulted significant reductions in the 
ROM of the exercised arm.  The decreases in ROM were significant after 60 
repetitions (8˚) and 72 repetitions (10˚), but not after 48 repetitions (7˚). These 
were unexpectedly moderate decreases in ROM compared to other work.  For 
example a reduction in ROM of the elbow flexors of nearly 20˚ has been recorded 
after 24 maximal eccentric contractions (Nosaka et al., 2002) and 50 maximal 
eccentric contractions (Tanabe et al., 2015).  After 60 a more marked reduction of 
25˚ has been recorded (Lau et al., 2015b). 
2.4.7 Anandamide  
In humans, AEA has been shown to at least double in response to endurance 
exercise, running for example (Raichlen et al., 2013; Sparling et al., 2003).  
However, in the present study there was no significant increase in AEA following a 
resistance exercise protocol.  Perhaps in a similar way to IL-6 the response differs 
between activities depending on metabolic cost. 
2.4.8 Methodological considerations 
Significant group differences may not have been detected because of the small 
sample size with 9 participants in the 48 and 60 rep groups but only 7 in the 72 rep 
group.  Group differences may have been underpowered, i.e. there may not be 
enough statistical power in a small sample size to detect significant effects (Cohen 
& Cohen, 1988).  In particular, the AEA results were based on 6, 3 & 2 participants 
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in the 48, 60 and 72 repetition groups respectively.  It should also be noted that 
disparity in trained versus untrained participants may have interfered with the 
results for some biomarkers, controlling for exercise in the 48 prior to the biceps 
curls may not have been enough.   
 Conclusions 
A large number of maximal eccentric elbow flexion exercises produces measurable 
changes in biomarkers associated with DOMS, whether that be 48, 60 or 72 
contractions.  The null hypothesis can be accepted as no significant differences 
were found between the three groups for any biomarker.  However, the within 
group response differed depending on the number of contractions and the 
biomarker involved showing more subtle effects.  If we were to consider the pain of 
DOMS in itself to be the most relevant biomarker then the highest mean score for 
the 60 repetition group would seem important.  And further, the increase in DOMS 
score for the 60 repetition group was highly significant (p=0.000).  In addition, 
DOMS significantly correlated with ROM, which significantly decreased for the 60 
and 72 repetition groups only.   Significant increases in UAC were only recorded for 
the 48 and 60 repetition groups, with no significant increase for the 72 repetition 
group.  Taken together the most appropriate number of repetitions for further 
testing would be the minimum number with the most response.  Therefore 60 
repetitions of maximal eccentric elbow flexion exercises were chosen for a 
nutritional intervention study. 
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Chapter 3  Phase two: Polyphenol Intervention.  
 Introduction 
Antioxidants may be useful to reduce the oxidative stress response brought about 
by strenuous exercise.  Aronia melanocarpa plants are widely found in Europe and 
the berries are considered to be one of the richest natural sources of antioxidants. 
The widely known antioxidant capacity of these berries is due to the concentrated 
levels of a group of bioactive compounds known as polyphenols.  Exercise-induced 
muscle damage as a result of contractional stresses give rise to tissue damage and 
a stress response.  This stress response results in oxidative stress and the 
production of reactive oxygen species (ROS).  Antioxidants scavenge ROS and may 
attenuate some biomarkers of exercise-induced muscle damage (EIMD), for 
example, it has been shown to attenuate DOMS (Udani et al., 2009). 
3.1.1 Polyphenolic compounds and health 
Supplementation with berry extracts has been extensively studied of late for 
positive health effects, among them, Aronia melanocarpa for being one of the most 
active and richest sources of bioactive compounds (Lou-Bonafonte, Gabás-Rivera, 
Navarro, & Osada, 2017).  Polyphenols, from Aronia melanocarpa have been shown 
in vitro to have a powerful antioxidant and anti-inflammatory effect (Gao et al., 
2018).  Particularly high levels of three classes of polyphenols: anthocyanins, 
proanthocyanidins and flavonols establish Aronia melanocarpa berries as a food 
supplement of interest to the research community.  Consequently, research to 
further strengthen the association between these berries and anti-cancer, 
antibacterial and anti-inflammatory effects among others, is ongoing (D'Archivio et 
al., 2008; Dayem et al., 2016; Shukla & Mehta, 2015; Strugała, Gładkowski, 
Kucharska, Sokół‐Łętowska, & Gabrielska, 2016).  In an animal model, 
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supplementation of Aronia melanocarpa juice reduced chemically induced oxidative 
stress by 92% (Kujawska, Ignatowicz, Ewertowska, Oszmiański, & Jodynis-Liebert, 
2011).  On a cellular level polyphenols reduce oxidative stress in skeletal muscle by 
scavenging reactive oxygen species (ROS) which are known to cause cell damage 
(Goutzourelas et al., 2014).   
 
The damaging effects of ROS have been well researched since being discovered in 
the 1950’s (Gerschman, Gilbert, Nye, Dwyer, & Fenn, 1954).  However, the role of 
ROS is more complex than originally understood, alongside the seemingly 
detrimental effects of ROS in skeletal muscle, these reactive molecules also have a 
positive effect on force production and regulate cell signalling pathways (McClung, 
Judge, Powers, & Yan, 2010; Powers & Jackson, 2008).  In the exercise arena a few 
recent studies of athletes ingesting an Aronia-citrus drink reported an improvement 
in oxidative stress and inflammation.  Furthermore, a positive effects on DNA 
repair, the central nervous system and the cardiovascular system were noted 
(García-Flores, Medina, Cejuela-Anta, et al., 2016; García-Flores et al., 2018; 
García-Flores, Medina, Oger, et al., 2016). 
3.1.2 Antioxidants, exercise and DOMS 
The limited understanding of the relationship between exercise, DOMS and ROS is 
partly due to the complex nature of ROS, the many species involved and the 
difficulty in accurately assessing those species (Jackson, 2016).  Increased 
oxidative stress typically occurs in response to exercise, particularly prolonged 
endurance exercise or heavy bouts of resistance training (Howatson et al., 2010; 
Tomeleri et al., 2018).  The oxidation of fatty acids and carbohydrates to meet the 
energy demands of exercise increase ROS in muscle tissue (Bailey et al., 2007; 
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Meisenberg & Simmons, 2012). The increase in ROS is generated by many 
biochemical processes, increases in the xanthane oxidase enzyme for example.  In 
an animal model, an eccentric exercise protocol producing significant increases in 
xanthane oxidase also produced a concomitant increase in DOMS pain behaviours 
(Retamoso et al., 2016).  Oxidative stress research in vivo in animals can be 
challenging, in humans more so (Jackson, 2016).  Despite these challenges, 
understanding of exercise-induced oxidative stress has expanded over the last two 
decades (Powers, Radak, & Ji, 2016).  Most notably, the discovery that; 
susceptibility to EIMD was increased when an antioxidant deficiency was present, 
and that; the endogenous antioxidant system protected against EIMD (Powers et 
al., 2016).   
 
It has previously been observed that ROS elevations following a bout of exercise 
leads to an increased demand for antioxidant substances (Ji, 1995), and that 
antioxidant supplementation increases antioxidant status and mediates exercise-
induced oxidative stress (Del Bo, Martini, Porrini, Klimis-Zacas, & Riso, 2015).  
Therefore, the effects of dietary antioxidant interventions on exercise-induced 
changes in biomarkers has been extensively studied, however, results can be 
somewhat conflicting.  On a simple level, a reduction in exercise-induced oxidative 
stress following antioxidant vitamin supplementation has been shown with vitamins 
C & E (Machefer et al., 2007).  Furthermore, in one study, acute vitamin C 
supplementation resulted in a reduction of DOMS of up to 44% (Kaminski & Boal, 
1992).  However, conclusions drawn from Kaminski and Boal (1992) are limited by 
the small sample size and the lack of an untreated control group.  More recent 
research that used vitamin C, has shown a reduction in ROS without a reduction in 
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DOMS (Close et al., 2006).  In a recent review of the effects of vitamin C & E on 
EIMD, it was concluded that there was no direct evidence that these vitamins 
reduce exercise-induced ROS.  The final conclusion in that review was that it was 
still worth considering other methods of reducing ROS with alternative antioxidant 
interventions (Cobley, McHardy, Morton, Nikolaidis, & Close, 2015), polyphenolic 
compounds for example.  Supplementation with polyphenols as opposed to 
antioxidant vitamins, has also been shown to reduce the oxidative stress brought 
about by exercise (Levers et al., 2016).   In addition, the polyphenolic compound 
Curcumin has been shown to significantly reduce DOMS, though the mechanism of 
action remains unclear (Drobnic et al., 2014).  Other agents that have a direct 
effect in exercised muscle have been tested as DOMS reducing agents.  Ginseng for 
example interferes with the calcium efflux from exercising muscles and has been 
successfully used to reduce DOMS pain (Pumpa et al., 2013).  Bromelain in 
pineapple juice, which inhibits pro-inflammatory agents and stimulates anti-
inflammatory agents in muscle has also been shown to be a more successful DOMS 
reducing agent.  Interventions using bromelain have resulted in a significant 
reduction of DOMS pain (Miller, Bailey, Barnes, Derr, & Hall, 2004; Udani et al., 
2009).  However, the evidence is equivocal, others have found no significant effect 
on DOMS pain with Bromelain (Beck et al., 2007; Stone, Merrick, Ingersoll, & 
Edwards, 2002).  It is important to note that each substance tested has its own 
biochemical properties and specific mode of action on ROS in vivo (Murphy et al., 
2011).  The biochemical effect of each nutritional intervention will effect indices of 
EIMD, including the pain of DOMS, in a specific and unique manner depending on 
the dose.   
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Chronic supplementation with a polyphenol rich compound can be effective for 
increasing exercise performance (Deley, Guillemet, Allaert, & Babault, 2017) and 
reducing unfavourable symptoms of EIMD, e.g. DOMS (Levers et al., 2016).  That 
being said, the effects of polyphenols on individual markers of EIMD, particularly 
DOMS, is not uniform across exercise research.  Research involving polyphenols 
from Montmorency cherries have produced mixed results, successfully prevented 
some of the symptoms of EIMD but not others.  For example, a polyphenol rich 
Montmorency cherry juice blend reduced self-reported pain scores for DOMS but 
had no effect on ROM (Connolly et al., 2006).  In other research, cherry juice 
attenuated the rises in IL-6 and CRP but did not reduce DOMS in marathon runners 
(Howatson et al., 2010).  Bell et al. (2016) later demonstrated the same 
attenuation of the inflammatory marker IL-6 with a corresponding reduction in 
DOMS following a sprint protocol.  Similarly, Levers et al. (2016) reported 
attenuation of DOMS soreness alongside a 47% reduction of inflammation markers 
after a half marathon following 10 days of powdered Montmorency cherry 
supplementation.  However, following a plyometric protocol with cherry juice 
supplementation, while the antioxidant capacity of the blood was increased by 67% 
there was no effect on CK or DOMS (Hillman, Taylor, & Thompkins, 2017).  One 
explanation of the differences in effect and magnitude of the above interventions on 
EIMD is the variety of exercise protocols employed.  Moreover, individual studies 
provide a different Montmorency cherry supplement, each with a unique 
polyphenolic profile.  
 
Cherries are known for their numerous polyphenolic anti-inflammatory and 
antioxidant agents, and have been shown to significantly reduce biomarkers of 
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inflammation (Kelley, Rasooly, Jacob, Kader, & Mackey, 2006).  The consumption of 
cherries is therefore receiving attention in the exercise physiology and biochemistry 
arena.  How consumption of these berries specifically affect individual biomarkers of 
oxidative stress and EIMD has been investigated.  For example, haematological 
results following 28 days of sweet cherries consumption showed a reduction in the 
inflammatory markers; Nitric oxide (NO), C-reactive protein (CRP), and tumour 
necrosis factor alpha (TNF-α). The cytokine Interleukin-6 (IL-6) however, was 
unaffected.  Though these results demonstrated the effect of cherries on 
inflammatory markers, clear individual differences in response to the sweet cherry 
intervention were noted (Kelley et al., 2006).  In contrast, Lynn et al. (2014) 
reported no effect of Montmorency cherry (Prunus cerasus) juice consumption on 
CRP as a biomarker for inflammation (Lynn et al., 2014).  No influence on CRP was 
also reported in a later study using Montmorency cherry, in this case though, IL-6 
and DOMS were both attenuated (Bell et al., 2016).  When Elite weightlifters 
consumed either pomegranate juice containing a total of 20,480mg of polyphenols 
or a placebo, the pomegranate juice caused a suppression of oxidative stress 
markers which was not seen with the placebo (Ammar et al., 2016).  In this case, 
the pomegranate juice did not attenuate DOMS, however, the juice significantly 
reduced CK (p<0.001).  In addition, there was a highly significant correlation 
between DOMS and CK (p<0.001, r=0.8).   
 
Each berry species has a unique polyphenolic profile and subsequent antioxidant 
activity.  Polyphenols, from Aronia melanocarpa for example, have been shown to 
have a powerful antioxidant and anti-inflammatory effect (Gao et al., 2018).  
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Most antioxidant interventions in exercise research involved chronic or acute 
supplementation with a polyphenol rich compound, however, few involving Aronia 
melanocarpa.  There has been some success with chronic supplementation of 
Aronia melanocarpa juice on markers of exercise-induced oxidative stress.  For 
example, a daily Aronia-citrus juice reduced biomarkers of inflammation and 
oxidative stress in triathletes during a 21week training programme (García-Flores 
et al., 2018).  
3.1.3 Polyphenols in berry fruits  
Powdered berry fruits are more a more concentrated source of polyphenols than 
berry juice products.  In addition, the phenolic content significantly differs between 
commercially available fresh juice products with up to four times the polyphenol 
content in some products compared to others (Sosnowska et al., 2016).  Juice 
production from berry fruits creates 70-80% juice and 20-30% by-product known 
as pomace.  The pomace by-product contains high levels of fibre and polyphenolic 
compounds and is therefore a valuable source of antioxidants.  Berry pomace 
comprises mostly of fruit skin where concentrations of polyphenolic compounds are 
high, drying the pomace condenses and preserves much of the antioxidant 
compounds that remain in the skin following juice production (Brazdauskas, 
Montero, Venskutonis, Ibañez, & Herrero, 2016).  The pomace as a by-product also 
contains especially high levels of the class of polyphenols known as anthocyanins 
(Oszmiański & Lachowicz, 2016).  Powdered berry products are therefore 
exceptional as a nutritional source of polyphenol compounds  
 
The levels of phenolic compounds found in berry fruits depends on the stage of 
ripening, e.g. total phenolic compounds decrease as the fruit ripens and total 
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anthocyanin content increases (Karaaslan, Yılmaz, Karaaslan, & Vardin, 2016).  
Following harvesting of Aronia melanocarpa the drying process can significantly 
reduce the total phenolic content (TPC), freeze drying is a key method which 
preserves 90% of the phenolic compounds.  This process results in a total 
polyphenol content (TPC) of 7265mg/100g dry mass and 2227mg/100g dry mass of 
whole dried berries (Samoticha, Wojdyło, & Lech, 2016).  However, the processing 
method of berry products can actually increase the resulting Polyphenol content.  A 
combination of drying, using pectinolytic enzymes and milling the pomace increases 
the available polyphenols by more than double.  And further, milling the pomace 
into smaller particles (Micro-milling) increases the TPC by a further 25%.  In that 
study, Aronia melanocarpa pomace after course milling contained total polyphenols 
of 3,100–6,300mg/100g dry mass (dm) and 1190-1950mg/100g dm of 
anthocyanins.  However, with micro milling this increased to 10,800mg/100g dm 
and 2,280mg/100g dm for TPC and anthocyanins respectively (Mayer-Miebach, 
Adamiuk, & Behsnilian, 2012).  An integrated extraction-absorption processing 
maximises the extraction rate of almost all of the extractable polyphenols (Vauchel, 
Galván D'Alessandro, Dhulster, Nikov, & Dimitrov, 2015). 
 
The polyphenol content of cherry fruit depends on the variety, tart cherry (prunus 
cerasus) tend to have substantially higher levels than sweet cherry (prunus avium) 
varieties.  Compared to the sweet cherry variety Bing (prunus avium), the TPC 
content of the tart cherry Montmorency (prunus cerasus) was three times higher.  
That being said, the anthocyanin content was similar in both varieties (Picariello, De 
Vito, Ferranti, Paolucci, & Volpe, 2016).   The highest polyphenol content of eight 
cherry varieties analysed (as fresh weight) was found to be the white variety of 
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prunus tomantosa at 8.33mg/g (fw), followed by the popular prunus cerasus with 
6.06mg/g (fw) (Cao et al., 2015).  Measured on a dry mass basis Wojdyło, 
Nowicka, Laskowski, and Oszmiański (2014) reported the TPC of prunus cerasus 
cherries as 29.83mg/g (dm) and total anthocyanin content (TAC) as 9.94mg/g 
(dm).  Aronia melanocarpa on the other hand contain more than double the TPC at 
72.65mg/g (dm) and TAC at 22.27mg/g (dm) (Samoticha et al., 2016).  The most 
abundant anthocyanin in Aronia melanocarpa determined as cyanidin-3-galactoside 
(Ćujić et al., 2016).  
3.1.4 Antioxidant activity of polyphenols in berry fruits  
The antioxidant capacity of berry products as a result of the antioxidant compounds 
present can be tested in vitro.   The oxidant scavenging activity of berries is 
measured in several ways, the most common methods are; oxygen radical 
absorbance capacity (ORAC), ferric ion reducing antioxidant power (FRAP) and 2,2-
diphenyl-2-picrylhydrazyl (DPPH). These methods measure different types of 
scavenging activity, all three methods are standardised and expressed as Trolox 
Equivalents (TE).  
 
The ORAC method measures total antioxidant capacity by introducing a substance 
to free radical generators and recording how much that substances neutralises 
these radicals.  Berry extracts were exposed to peroxyl radicals generated by 2,2′-
Azobis(2-amidinopropane) dihydrochloride (AAPH), and the scavenging activity 
recorded.  Measured on a fresh weight (fw) basis, the ORAC of berry fruits have 
been reported as follows: gooseberry (Dovyalis hebecarpa) 50.1µmol TE/g (Bochi, 
Barcia, Rodrigues, & Godoy, 2015); Morello cherry (Prunus cerasus) 38.9µmol TE/g 
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(Picariello et al., 2016); chokeberries (Aronia melanocarpa) 158.2µmol TE/g (Wu, 
Gu, Prior, & McKay, 2004).   
 
Results of antioxidant activity measured as FRAP on a dry mass (dm) basis were as 
follows: tart cherry (Prunus cerasus) 12.95mmol TE/100g (Wojdyło et al., 2014); 
chokeberry pomace (Aronia melanocarpa) 47.38mmol TE/100g (Tolić et al., 2015); 
chokeberry pomace (Aronia melanocarpa) 53.78mmol TE/100g (Oszmiański & 
Lachowicz, 2016).   Interestingly (Oszmiański & Lachowicz, 2016) compared Aronia 
melanocarpa juice to pomace on a dry weight basis and recorded DPPH as 
127.45µM Trolox/100g and 301.89µM Trolox/100g respectively.    
 
The above results were measured in vitro and as such do not take into account 
bioavailability and bioactivity within a living organism.  In vivo studies in humans 
reveal factors that reduce the scavenging capacity of antioxidant compounds 
including but not limited to: absorption in the gut, genetics, medication and the 
food matrix (Holst & Williamson, 2008).  Polyphenols after absorption in the gut are 
extensively modified and as such are chemically, biologically and functionally very 
different substances by the time the reach target cells and tissues (D'Archivio, 
Filesi, Varì, Scazzocchio, & Masella, 2010).   The metabolites produced in vitro can 
be measured in plasma and urine to indicate antioxidant activity within the body, 
however, this is again subject to individual variability. 
 
The uptake and excretion of anthocyanin metabolites varies greatly between 
individuals, excretion varying by a magnitude of ten between only 17 participants 
(Kalt, McDonald, Vinqvist-Tymchuk, Liu, & Fillmore, 2017).  Feliciano, Istas, Heiss, 
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and Rodriguez-Mateos (2016) illustrated that this variability is due to individual 
differences in phase II enzymes and gut microbiota involved in the absorption and 
metabolism of polyphenolic compounds. Add in here polyphenol uptake kinetics 
section (Myburgh, 2014). 
 
Like antioxidant vitamin C, anthocyanins would seem to be excreted via urine in a 
matter of hours.  (Wiczkowski, Romaszko, & Piskula, 2010) reported that ingesting 
Aronia melanocarpa resulted in the presence of cyanidin metabolites in both blood 
and urine.  Cyanadin-3-galactoside was measure by HPLC and found to make up 
66% of the polyphenol profile of the Aronia melanocarpa ingested by the 
participants.  The cyanidin metabolites peaked in blood at 1.3h and the urine 
excretion rate peaked in the first two hours, both measures returned to baseline 
within 24 hours.  Exercise appears to increase bioavailability of polyphenolic 
compounds.  A five-fold increase in urinary anthocyanin metabolites has been 
shown in athletes who consumed Aronia melanocarpa juice 15 minutes after 
training compared to untrained controls (Medina et al., 2012).  Anthocyanin 
metabolites in urine and plasma roughly correlate (Kalt et al., 2017), and individual 
anthocyanin metabolites from Aronia melanocarpa peak in plasma between 1h and 
6h (Xie et al., 2016).  
3.1.5 Summary 
Generally, antioxidant interventions involving vitamins C and E have little effect on 
muscle damage or pain (Urso, 2013).  However, each oral intervention reduced 
inflammation in a very specific and complex way, for example; Vitamin C reduces, 
among other things, superoxide production (Cobley et al., 2015), and NSAIDS 
reduce prostaglandins by blocking the cyclo-oxygenase (COX) enzyme (Schoenfeld, 
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2012).  There is a great diversity of antioxidant interventions, each with a unique 
and complex biochemical action.  This leaves the possibility that further research 
has yet to uncover an intervention that reduces pain without detriment to 
adaptations.   
 
Antioxidant substances such as Aronia melanocarpa may be useful in reducing 
exercise-induced oxidative stress.  Aronia menalocarpa is a potent antioxidant 
containing high levels of polyphenols.  Polyphenols have been shown to affect 
biomarkers of EIMD including DOMS, however, the evidence is equivocal.  A single 
dose of Aronia melanocarpa has not been tested in an exercise intervention as a 
DOMS reducing agent. 
3.1.6 Aims 
To test the effect of a high dose of polyphenol rich Aronia melanocarpa on the 
biomarkers associated with DOMS. 
3.1.7 Hypothesis 
H0 A single dose of Aronia melanocarpa extract has no effect on the biomarkers of 
delayed-onset muscle soreness (DOMS).  
 Materials and Methods 
3.2.1 Participant volunteers 
See section 2.2.1 above. 
A total of 21 male university staff and students volunteered to participate in the 
DOMS antioxidant intervention study.  Details of the second study were provided by 
verbal briefings and participant information sheets (Appendix 6).  Participants were 
fully informed of procedures and risks before providing written informed consent 
(Appendix 7).   
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3.2.2 Experimental Design 
This study utilised a randomised, single blind, placebo controlled independent group 
design. Participants attended the Exercise Physiology Laboratory at the University 
of Huddersfield to perform an eccentric exercise intervention on an isokinetic 
dynamometer (Cybex, USA).  Biomarkers (including pain scores) were taken at 
three time points: before the exercise intervention (time point A), after exercise 
intervention (time point B) and at follow up 48 hours later (time point C) (figure 
21). Participants were given an Aronia/placebo beverage after biomarkers were 
recorded and within half an hour of cessation of the exercise protocol.  
 
 
 
 
Figure 21. Overview of experimental design.  The exercise intervention to induce 
DOMS was performed immediately following baseline biomarker measurements 
taken at time point A.  Biomarker measurements were then repeated at time points 
B and C.  Measurements recorded at each timepoint: upper arm circumference 
(UAC), range of motion (ROM) of the exercised arm, a recording of pain (VAS) in 
the biceps brachii and blood sampling took place.   
 
3.2.3 Beverages 
Aronia powder was milled for three minutes in a Nutribullet 600W blender 
(Nutribullet LLC.) to reduce particle size, then sieved to a particle size of <425µm.  
The manufactures recommended intake for this product was 1-2 tablespoons per 
day, the lower end of this recommendation i.e. 1 tablespoon (18.2g) was tolerated 
well in smoothie taste tests and was subsequently used in the experimental group 
drink.  This quantity of Aronia powder would provide approximately 405.31mg of 
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polyphenols (Samoticha et al., 2016), and 9.79mmol TE of Ferric Ion Reducing 
Power (FRAP) (Oszmiański & Lachowicz, 2016).   With regard to food allergies, 
participants were given a list of possible ingredients in their beverage before 
consumption (Appendix 8).  The ‘Canderel spoonful’ sweetener contained a source 
of phenylalanine, the label was shown to participants to avoid consumption by 
participants with phenylketonuria. 
 
Recipes for the Aronia/placebo beverages were as follows (appendix 9) 
 
Experimental Aronia beverage; 
60g Fresh banana 49kcal 
120ml Sainsbury’s Pineapple juice (ambient) 60kcal 
18.2g Biojoy Aronia Pomace Powder 51kcal 
1g Canderel Spoonful sweetener 4kcal 
Total Kilocalories 164kcal 
 
Macronutrient composition;   
Energy 164kcal 
Carbohydrate 31.66g 
   of which sugars 25.39g 
Fat 0.62g 
   of which Saturates 0.16g 
Protein 2.04g 
 
 
Isocaloric Placebo beverage; 
60g Fresh banana 49kcal 
222ml Sainsbury’s Pineapple juice (ambient) 111kcal 
1g Canderel Spoonful sweetener 4kcal 
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Total Kilocalories 164kcal 
 
Macronutrient composition;   
Energy 164kcal 
Carbohydrate 38.43g 
   of which sugars 34.68g 
Fat 0.0g 
   of which Saturates 0.0g 
Protein 0.73g 
 
 
All beverages were blended in the Nutribullet for 30 seconds and served in a dome 
topped smoothie cup with three ice cubes and a jumbo straw.  The drinks were 
formulated and made up by a nutritionist.  Participants ingested the smoothie drink 
within 30 minutes of cessation of the exercise protocol, and consumption was 
confirmed through direct observation by the nutritionist.  Calorific values were 
taken from packaging and recorded in kilocalories (kcal), with the exception of 
fresh banana.  The caloric values for 60g of fresh banana was taken from the 
McCance and Widdowson nutrient tables. 
3.2.4 Perceived Muscle Soreness 
See section 2.3.3 above. 
3.2.5 Creatine Kinase 
See section 2.3.6 above. 
3.2.6 Upper Arm Circumference  
See section 2.3.4 above. 
3.2.7 Range of Motion  
See section 2.3.5 above. 
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3.2.8 Variables 
The independent variable (IV) was exposure to the Aronia or placebo beverage. 
Dependent variables comprised of the subsequently recorded biomarkers at time 
point A (before exercise), time point B (after exercise), and time point C (48 hours 
later).  Dependant variables (DV’s) were as follows: DOMS, UAC, ROM and CK. 
3.2.9 Statistical methods 
Statistical analysis was performed using SPSS version 24 (IBM Corp. USA) with the 
significance level set at p>0.05 for all analyses.  To determine normality, these 
data were assessed both visually (histograms) and statistically using the Shapiro-
Wilk test for normality. Assumptions of homogeneity of variance were tested using 
the Levene’s test for equality of variances.  Central tendencies and measures of 
spread were derived for the DV’s and expressed as mean ± standard deviation (SD) 
or median with interquartile range (IQR).    
 
Significant main time effects were assessed using paired sample t tests for DOMS, 
and UAC.  To detect significant differences at baseline, baseline data for these 
variables was compared between Aronia and control conditions using independent 
samples t-tests.  Significant time effects within each condition, i.e. Aronia and 
control, were assessed using paired sample t tests.  This entailed performing a 
within group comparison between baseline and 48 hours for DOMS and UAC.  Group 
x time interactions were assessed using independent samples t test.  A paired 
sample t test was then used to assess the effect of the Aronia beverage on change 
over 48 hours for DOMS and UAC.  Where significant p values were returned for 
interaction effects (time x condition), Aronia was deemed to have influenced the 
response.  Where significant differences were identified, 95% confidence intervals 
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were used to present the estimation of mean differences.  Finally, Pearson product 
moment correlations were used to assess the relationship between DOMS scores 
and other outcomes. 
 
To determine normality, CK data were assessed both visually (histograms) and 
statistically using the Shapiro-Wilk test for normality.  For CK and ROM, non-
parametric tests were used to assess baseline data (Wilcoxen Signed Rank Test), 
main time effects, and main time x condition effects (Mann-Whitney U) of these 
variables.  Correlations with other dependent variables was assessed using a non-
parametric Spearman’s Rho correlation.  
 Results 
3.3.1 Study population 
Twenty-one volunteers were assessed for eligibility before taking part in the study.  
Of those volunteers, three did not report back to the physiology laboratory for 
follow up biomarkers. One participant had implausibly high CK at baseline and was 
excluded from any further analysis.  Full blood samples were not possible for two 
participants and were excluded from blood biomarker analysis only.  A total of 17 
volunteers (27.1 ± 10.2 years; 77.8 ±10.3 kg; 177.7 ± 7.0 cm) completed the 
experimental protocol and were included for statistical analysis.  
3.3.2 Indicators of Muscle damage 
There were no significant differences between the experimental and control groups 
for any baseline measure.  The exercise protocol was sufficient to induce significant 
changes in muscle damage biomarkers.  A significant main time effect between 
baseline and 48 hours were found for; increases in DOMS (p=0.000) & creatine 
kinase (p=0.015); and decreases in ROM (p=0.004) & Anandamide (p=0.033).  
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Main time effect for increases in upper arm circumference approached significance 
(p=0.061). Table 3 shows mean and median values for soreness, upper arm 
circumference, range of motion and CK activity. The data for ROM and CK did not 
follow a normal distribution both visually (histogram) and statistically (Shapiro-
Wilk), non-parametric tests were subsequently used for these data.  All other 
variables returned a non-significant result on the Shapiro Wilk test, indicating a 
normal distribution of these data. Table 4 shows mean biomarker values for all 
variables by experimental and control group. 
 
Table 3.  Biomarkers of Exercise-induced Muscle Damage 
 
Biomarker 
Time point A 
Baseline 
Time point B 
After exercise 
Time point C 
48 hours 
Soreness (VAS 0-10) 0.00 ± 0.0 2.3 ± 1.8*** 4.7 ± 2.2*** 
Creatine Kinase (IU/L) 91.6 (78.6) 89.6 (81.9) 153.0 (1258.6)** 
Upper Arm Circ (cm) 31.5 ± 4.0 31.9 ± 3.9** 31.8 ± 3.9 
Range of motion (Degrees) 150.0 (13.0) 135.0 (16.0)** 138.0 (13.0)** 
    Mean (SD)/median (IQR) values at baseline, immediately after and 48 hours after exercise for all participants 
(n=17).  Asterisk superscript ** and *** denotes a significant difference relative to baseline within a group p<0.01 
and p<0.001 respectively.   
 
3.3.2.1 Perceived Muscle Soreness  
There was a significant main time effect on DOMS ratings following the exercise 
protocol (p=0.000).  All participants reported an increase in soreness after 48 hours 
(figure 22).  Ratings of perceived muscle soreness did not differ between the two 
groups at baseline (p=0.000).  After 48 hours, participants in the Aronia group 
reported 14% less pain than in the control group with mean increases in pain 
scores of 4.4cm (±2.2) and 5.1cm (±2.2) respectively.  However, the difference in 
pain scores did not reach statistical significance (p=0.556). 
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Figure 22. Increases in DOMS pain scores relative to baseline by Aronia 
melanocarpa (experimental) and control group.  Mean ± SD values for each group 
are shown.  No significant differences between groups were found (p=0.556).  
Asterisk superscript *, ** and *** denotes a significant difference relative to 
baseline within a group p<0.05, p<0.01 and p<0.001 respectively.  
  
3.3.2.2 Creatine Kinase  
There was a significant main time effect for CK activity (p=0.015).  Plasma CK had 
significantly increased by 462% (p=0.036) in the placebo group.  Plasma CK 
increased by 226% in the Aronia group, however this did not reach significance 
(p=0.173).  Though CK activity in the Aronia group showed no significant difference 
between baseline and 48 hours (compared to a significant time effect in the control 
group), no significant group x time effect was found (p=0.248).  Plasma CK activity 
was not significantly different between the two groups at any timepoint; baseline 
(p=0.736), immediately following exercise (p=0.847), and at 48 hours (p=0.191) 
(figure 23).   
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Figure 23. Change in Creatine Kinase activity relative to baseline by Aronia 
melanocarpa (experimental) and control group.  Median ± IQR values for each 
group are shown.  The Aronia group’s CK values remained near baseline for the 48 
hour period.  No significant differences between groups were found (p=0.191).  
Significantly different to baseline p<0.05*. 
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Table 4. Biomarker outcomes displayed as mean (SD) or median (IQR). 
  
 
      
 
Aronia (n=9)  Control (n=8)  
between 
groups; p 
 Baseline 48 hours  Baseline 48 hours   
        
DOMS 
(VAS 0-10) 
0.0 ± 0.0 4.4 ± 2.2***  0.0 ± 0.0 5.1 ± 2.2***  p=0.556 
        
UAC (cm) 31.0 ± 3.6 31.1 ± 3.5  32.1 ± 4.6 32.5 ± 4.4  p=0.348 
        
ROM 
(Degrees) 
148.0 (18.0) 140.0 (6.0)  150.0 (10.0) 133.5 (29.0)*  p=0.177 
        
CK (IU/L)   91.6 (51.8) 124.0 (108.6)*  94.6 (286.8) 1305.0 (1276.9)*  p=0.248 
        
         
        
Significance assessed by t-test for Soreness, and UAC. Significance assessed for CK and ROM with the 
Mann Whitney U test.  Asterisk superscript * and *** denotes a significant difference relative to baseline 
within a group p<0.05 and p<0.001 respectively.  
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3.3.2.3 Upper Arm Circumference 
There was no main time effect for UAC, but this did approach significance 
(p=0.061).  The UAC was not significantly different at 48 hours compared to 
baseline for either the Aronia group (p=0.468), or the control group (p=0.063).  
Homogeneity of variance was assumed according to Levene’s test (p=0.844). There 
was no significant group x time interaction (p=0.348) (figure 24). 
  
Figure 24. Changes in upper arm circumference (UAC) relative to baseline by 
Aronia melanocarpa (experimental) and control group.  Mean ± SD values for each 
group are shown.  No significant differences between groups were found (p=0.348).  
Upper arm circumferences did not significantly change from baseline for either the 
Aronia melanocarpa (experimental) and control group.   
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3.3.2.4 Range of Motion 
There was a significant main time effect immediately after the exercise protocol 
(p=0.001) and after 48 hours (p=0.004) compared to baseline (table 3).  There 
was a significant reduction in the range of motion of the elbow joint over 48 hours 
of 13.5° (p=0.012) in the control group.  There was no difference in ROM between 
baseline and 48 hours in the Aronia group (p= 0.122).  No significant group x time 
interaction (p=0.177) was found (figure 25).  
   
Figure 25.  Changes in the range of motion (degrees) of the elbow joint relative to 
baseline by Aronia melanocarpa (experimental) and control group.  Median ± IQR 
values for each group are shown.  No significant differences between groups were 
found (p=0.556).  *Significantly different to baseline p<0.05. 
 
 Discussion   
The present study evaluated the effects of a single dose of polyphenols (Aronia 
melanocarpa) on DOMS related indices of muscle damage 48 hours after an acute 
bout of exercise.   The exercise protocol was sufficient to induce DOMS pain as well 
as post exercise alterations in the other indices analysed; CK, IL-6, UAC & ROM.  
Similar changes have been reported in other studies (Guilhem et al., 2013; Lau et 
al., 2015b; Nosaka et al., 2002; Tanabe et al., 2015).  Increases in the skeletal 
muscle enzyme CK and the cytokine IL-6 confirmed EIMD was sufficient to evaluate 
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the potential effects of a dietary antioxidant supplement on DOMS.  The Aronia 
group had a lessor response to the bicep curl exercise protocol.  The Aronia group 
reported less pain although this did not reach significance.  Increases in CK activity 
in response to the exercise protocol in the Aronia group were half that of the 
control group, and a decrease in ROM only occurred in the contro 
3.4.1 Polyphenols and DOMS 
The effect of polyphenols on DOMS pain is limb specific.  Though there is some 
evidence to suggest that polyphenols have no effect on DOMS pain for either arms 
or legs (Machin et al., 2014), other research has found that arms and legs respond 
differently (Ammar et al., 2016).  These differences may be explained by the 
different methodologies.  In research conducted by Machin et al. (2014), downhill 
running versus maximal eccentric elbow flexion was used, which may not have a 
comparable eccentric element.  In research conducted by Ammar et al. (2016), 
comparison between limbs was possible because the ‘clean & jerk with squat’ 
provided resistance exercise that was heavily eccentric on both arms and legs.  The 
polyphenol supplement resulted in a significant improvement in DOMS pain in the 
legs but this effect was absent in the elbow flexors.  This indicates that polyphenols 
have a lesser effect on DOMS in the elbow flexors, which may be one of the reasons 
that the effect on DOMS in the present study was minor. 
 
Utilising a similar design to the present study, but using a chronic supplementation 
strategy, a mixed polyphenol powder containing pomegranate, mangosteen and 
elderberry was shown to significantly reduce DOMS (Romain et al., 2017).  The 
polyphenol rich powder contained a TPC of 146.1mg/g and anthocyanin content of 
3mg/g.  This equated to a total dose of 1,095.75mg of polyphenols which is more 
than twice as much as the 405.31mg single dose given in the present study.  With 
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the pomegranate, mangosteen and elderberry intervention, DOMS pain was 
significantly lower after 48 hours when DOMS was attenuated by 33% (p=0.008) 
(Romain et al., 2017).   The reduction in pain in the present study with acute 
supplementation was a much smaller 14% after 48 hours and did not reach 
significance.  The large reductions in pain demonstrated in Romain et al. (2017) is 
likely due to the chronic versus acute supplementation strategy, in that the 
1,095.75mg dose of polyphenols was ingested in 15 equal doses over a five-day 
period starting on the day of exercise.  Similar results were reported following 
chronic supplementation over an eight-day period starting four days before 
exercise.  This resulted in a 31% reduction in DOMS (p=0.017) 48 hours after 
cessation of the exercise protocol (Connolly et al., 2006).  In Connolly et al. (2006), 
the total dose of polyphenols was 9,600mg, of which, 640mg was anthocyanins.  
This again was double the 405.31mg of polyphenols in the present study.  It has 
been shown that anthocyanins reach maximal concentrations between 1 and 6 
hours post ingestion after which point, plasma concentration begin to fall (Myburgh, 
2014).  And further, that the resulting plasma metabolites do not bioaccumulate, 
and that repeated dosing is required to maintain levels in the blood (Feliciano et al., 
2016).  It seems likely therefore that chronic supplementation over a period of days 
using the same quantity of Aronia powder in the present study would significantly 
reduce DOMS.  However, it is also clear that the polyphenolic profiles of each 
supplement differ which in itself will have an impact on the efficacy of each 
supplemental regimen.  And further, a whole array of metabolites appear in plasma 
following ingestion of polyphenols and the effects of individual metabolites are not 
yet clear.  What is also interesting about research where DOMS has been 
significantly reduced with polyphenols is the effect on performance markers, for 
example; 13% faster marathon (p=0.001) (Levers et al., 2016), strength loss 
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attenuation of 18% (P<0.0001) (Connolly et al., 2006), and 3% faster agility tests 
(p=0.017) (Bell et al., 2016).  
3.4.2 Polyphenols and Creatine Kinase 
The ingestion of polyphenols blunts the CK response to muscle damaging exercise, 
however, this effect is dose dependent.  The present study found no effect on CK 
activity following the ingestion of a single dose of Aronia melanocarpa, this may be 
because there was not enough bioactives produced in the blood by the dose given.  
The quantity of polyphenols, the number of doses given and the timing of those 
doses in relation to the bout of exercise effects the levels of bioactive compounds in 
the blood.  The levels of bioactive compound in the blood must be high enough to 
elicit an effect, and must coincide with the biochemical response to the exercise 
bout.  The levels of bioactives in the blood also varied depending on bioavailability, 
absorption kinetics and the polyphenolic profile of the supplement ingested.  
Maximum concentration in the blood are reached between 1.5hrs and 5.5hrs after 
ingesting a single dose depending on the polyphenols involved (Manach, 
Williamson, Morand, Scalbert, & Remesy, 2005).   It follows therefore that acute 
dosing with a single dose is likely to elicit a lesser effect than chronic dosing with 
several doses.  And further, higher doses over a longer period of time are likely to 
elicit a more powerful effect.  For example, chronic supplementation of curcumin 
resulted in significantly smaller increases in CK activity in the magnitude of -48% 
(McFarlin et al., 2016).  Conversely, Drobnic et al. (2014) found no effect of 
ingesting curcumin on CK activity.  Though these were both chronic doses, the 
contrast in results is likely to be due to amount and timing of the doses.  McFarlin 
et al. (2016) gave a higher dose over a longer period of time, i.e. 2400mg over 6 
days compared to (Drobnic et al., 2014) who gave 1600mg over 4 days.  Similar to 
the present study, the effect on CK can be absent altogether with an acute dose 
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(Peschek, Pritchett, Bergman, & Pritchett, 2013).  The present study found no 
significant difference between the supplemented and placebo groups for CK activity.  
It is likely that the polyphenol intervention did not result in sufficient bioactives in 
the blood to effect CK enough to show a statistically significant difference between 
the groups.  
Though significant differences are not always found, the blunting effect of 
polyphenols on exercise-induced CK activity may be apparent in subtle differences 
between experimental and control groups.  For example, though no significant 
difference in CK were found following ingestion of a polyphenol rich extract, the 
levels of CK returned to baseline quicker in the supplementation group (Romain et 
al., 2017).  Even when significant differences are not detected between groups, CK 
activity is often lower in the groups that ingest the polyphenols (Clifford et al., 
2016; Levers et al., 2016; McLeay et al., 2012).  In the current study, though CK 
activity increased by 226% in the Aronia group, this increase was not statistically 
significantly different from baseline values.  The control group saw an increase in 
CK activity of 462%, which was a statistically significant increase from baseline.  
Given that the 48-hour increase in CK was not statistically significant in the Aronia 
group it is likely that the polyphenol intervention produced a dampening effect on 
CK activity in this group.    Is also possible that the effects of the polyphenols would 
have become apparent after the 48 hour follow up in the present study.  The levels 
of CK are likely to still be rising at 48 hours and the blunting of the CK response 
may have become apparent after that time, i.e.  To illustrate this point, in both 
Tanabe et al. (2015) and McFarlin et al. (2016) where CK was significantly 
attenuated with curcumin, CK peaks were measured on day four and attenuated by 
56% and 69% respectively.   
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3.4.3 Polyphenols and inflammation 
The anti-inflammatory effect of polyphenols has been well documented 
(Goutzourelas et al., 2014; Howatson et al., 2010; Kujawska et al., 2011).  It 
would therefore seem logical that polyphenols would influence swelling and ROM. 
However, the evidence is equivocal at best (Urso, 2013).  In line with the present 
study, most evidence shows no effect of polyphenols on swelling of the exercised 
limb even though inflammation is reduced in the polyphenol groups.  Depending on 
the polyphenols, the suppression of inflammation is at its highest when metabolites 
peak between 1.5 and 5.5 hours after ingestion.  After this time, metabolites are 
being lost in urine, therefore the effects of a single dose are relatively short lived 
and repeated doses are required to sustain elevated metabolites capable of 
reducing inflammation.  As chronic supplementation with polyphenols brings 
inflammatory markers back to baseline quicker than placebo (Ammar et al., 2016), 
it seems logical that chronic doses would reduce swelling in the same timeframe.  
However, after chronic supplementation with quercetin, no effect on swelling was 
found (O'Fallon et al., 2012).   This evidence suggests that the anti-inflammatory 
effects of polyphenols do not extend to the swelling caused by EIMD.    
 
Polyphenols consumption may have a small effect on ROM.   ROM in the elbow is 
reduced as a consequence of an intense bout of elbow flexion exercises, with a loss 
of around 9˚s (T. C. Chen et al., 2009).  On the whole, supplementation with 
polyphenols does not significantly attenuate ROM.  It seems evident that even 
though the differences do not reach significance, the reduction in ROM in the 
polyphenol groups is lower than the placebo groups (Pereira Panza, Diefenthaeler, 
& da Silva, 2015).  For example, an acute dose of the polyphenol gingerol has been 
shown to have no effect on ROM.  However, the reduction in ROM was lower at all 
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timepoints in the gingerol group (Tanabe et al., 2015).  Even with chronic 
supplementation with gingerol, no group x time effect on ROM was reported, 
however, again the supplemented group showed a smaller reduction in ROM (Black, 
Herring, Hurley, & O'Connor, 2010).  The results in the present study were 
interesting because a small effect on ROM was evident i.e. there was a significant 
time effect on the range of motion of the elbow joint of -16.5° (p=0.012) in the 
control group but no time effect in the Aronia group (p= 0.122).  The absence of a 
time effect in the aronia group could indicate an attenuation of the loss of motion, 
even when a group effect was not apparent.   
 Conclusions 
The null hypothesis can be accepted as no significant differences were recorded 
between groups.  However, there were subtle within group differences.  For the 
measures of ROM and CK, there was no change in the Aronia melanocarpa group.  
In contrast, there was a significant decrease in ROM and a significant increase in CK 
in the control group.  This suggests that Aronia melanocarpa attenuated the 
response for these two biomarkers, though in such a small sample size group 
differences were too subtle to detect. 
Chapter 4  Thesis conclusion 
In this investigation the aim was to design an evidence based DOMS induction 
protocol that could be used to test an antioxidant intervention using Aronia 
melanocarpa extract.  This was successfully achieved in the two phases of this 
research.  To the best of the authors knowledge Aronia melanocarpa extract had 
not been tested as a strategy to reduce the pain of DOMS.   
 Protocol Development 
There is a large variation in exercise protocols used to induce DOMS for 
experimental testing.  For example, the biomarkers vary from one protocol to the 
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next as does the speed, number and type of contraction.  By reviewing the 
evidence for each aspect of DOMS induction protocols it was possible to construct 
an evidence based protocol with relevant biomarkers.  In phase one, a protocol was 
successfully developed which produced measurable changes in biomarkers of EIMD.  
Increases in pain, CK and swelling were recorded alongside a decrease in the 
elbow’s range of motion after 48, 60 and 72 repetitions of maximal eccentric 
isokinetic elbow flexion exercises.  Every participant experienced DOMS following 
each of the exercise protocols with the highest and most significantly increased 
(p<0.001) DOMS scores being recorded in the 60 repetition group compared to 
baseline.  Given also that no swelling was apparent in the 72 repetition group and 
no change in ROM in the 48 repetition group, 60 repetitions was the minimum 
number with the most pronounced response and was therefore deemed appropriate 
for antioxidant testing in phase two. 
 Protocol application 
Following the development of a successful DOMS induction protocol in phase one, it 
was now possible to use the protocol to test the effects of the ingestion of an 
antioxidant compound in phase two.  It was hypothesised that an antioxidant 
compound would reduce some of the symptoms associated with EIMD, in particular, 
DOMS.  The protocol established in phase one encompassed 60 repetitions of 
maximal eccentric elbow flexion exercises and a set of biomarkers that indicate the 
biochemical and physical response.  A similar biochemical response was seen in the 
control group in phase two compared to the 60 repetition group in phase one, e.g. 
pain 5.1 and 5.0 respectively.  The protocol replicated well with the addition of an 
antioxidant intervention and allowed for the comparison of the biochemical 
response between the experimental and control (who did not ingest a dose of 
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antioxidants) groups.  This meant that the effects of the antioxidant intervention 
could be reported. 
 Aronia melanocarpa intervention 
Ingestion of Aronia melanocarpa extract successfully altered the biochemical 
response to exercise.  Subtle within group effects suggest a single dose resulted in 
the blunting of some biomarkers of EIMD, specifically CK and ROM.  The normal 
increases in CK and decreases in ROM in response to a large number of elbow 
flexion exercises did not occur in the Aronia melanocarpa group.  This lack of 
change for ROM and CK in the experimental group suggests that Aronia 
melanocarpa ingestion in some way attenuated these responses.   In contrast, 
significant increases in CK and decreases in ROM were recorded in the control 
group.  And further, higher scores were recorded for swelling and pain in the 
control group.  Based on these results, it can be concluded that a single dose of 
Aronia melanocarpa had a blunting effect on some aspects of the biochemical 
response to a bout of eccentric exercise.   It is possible that several doses of Aronia 
melanocarpa would strengthen these effects and make significant differences 
between groups more statistically detectable, particularly with respect to DOMS 
pain. 
 Further Research 
There is still much to be discovered about the pain of DOMS and strategies to 
reduce that pain.  Aronia melanocarpa as an antioxidant intervention would seem to 
hold promise, though chronic rather than acute supplementation should be 
considered for future research.  Furthermore, as the mode of action of this 
supplement reduces oxidation, a proxy measure of ROS such as Malondialdehyde 
would be advantageous.  The Aronia melanocarpa intervention seemed effective on 
certain biomarkers, however a limited number of participants undoubtedly 
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underpowered the statistical analysis.  Therefore the main limitation of this 
research was the small sample size, a larger group size in future research would 
increase the statistical power and potentially be more likely to determine group 
differences (Cohen & Cohen, 1988). 
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Appendices 
Appendix 1 
Participant Information Sheet Phase 1 “DOMS Protocol” 
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Appendix 2 
Informed Consent form ‘DOMS protocol’ 
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Appendix 3 
Health Questionnaire 
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Appendix 4 
Participant testing record 
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Appendix 5 
Participant aftercare sheet 
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Appendix 6 
Participant Information Sheet Phase 2 “Aronia Intervention” 
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Appendix 7 
Informed Consent form ‘Aronia intervention’ 
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Appendix 8 
Smoothie ingredients sheet for participants. 
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Appendix 9 
Recipe Experimental and Control Smoothie Drinks. 
Experimental Smoothie Ingredients  
 
Quantity Calories 
Sainsbury’s pineapple juice (ambient) 120ml 60kcal 
Fresh Banana 60g 57kcal 
Biojoy Aronia Powder (425µm particle size) 18.2g 51kcal 
Canderel granulated bulk Sweetener 1g 2kcal 
 Total 170kcal 
 
Control Smoothie Ingredients 
 
Quantity Calories 
Sainsbury’s pineapple juice (ambient) 222ml 111kcal 
Fresh Banana 60g 57kcal 
Canderel granulated bulk Sweetener 1g 2kcal 
 Total 170kcal 
 
Procedure 
The ingredients for each drink were weighed into a Nutribullet cup using scales.  
The ingredients were then processed for 20 seconds in the Nutribullet 600w 
blender.  Each smoothie was decanted into a domed lid smoothie cup and 
refrigerated for up to two hours.  Three ice cubes and a straw were added before 
serving.  
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